




Title of Document:                            IDENTIFICATION AND                        
                                                          CHARACTERIZATION OF A HEME      
                                                          RESPONSIVE ELEMENT IN THE hrg-1  
                                                          PROMOTER 
                                       
                                     Jason Sinclair, Masters of Science, 2008 
 
 
Directed By:                                     Assistant professor Dr. Iqbal Hamza, Department 
                                                          of Animal and Avian sciences 
 
 
Despite its biological significance, little is known about how animals sense and respond 
to heme to maintain homeostasis.  C. elegans is a heme auxotroph, which makes it an 
excellent model to identify and dissect heme homeostasis pathways.  Using C. elegans 
we have identified HRG-1, a vesicular heme transporter that is transcriptionally 
upregulated when environmental heme is low.  The current study seeks to address how 
hrg-1 is regulated by heme.  Here, we show that a putative 23 base pair (bp) heme-
responsive element (HRE) and GATA-binding motifs are necessary for heme-dependent 
regulation of hrg-1.  The HRE comprises both enhancer and repressor elements and 
works in conjunction with ELT-2 to regulate hrg-1 expression.  We propose that the HRE 
could be used as a molecular tool in C. elegans to tightly regulate internal gene 
expression by modulating environmental heme.  Our ultimate goal is to identify the trans-
acting factor to eventually create a whole animal sensor for monitoring organismal heme 
homeostasis. 
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Chapter 1: Literature Review 
Introduction 
Iron is an essential nutrient for almost all living organisms.  Physiologically, the 
most important characteristic of iron is that it can exist in two oxidation states, Fe3+ and 
Fe2+.  This allows it to bind and release oxygen, which makes iron absolutely essential for 
oxidative metabolism.  Despite its necessity, however, iron deficiency remains a 
worldwide problem.  According to the World Health Organization, about thirty percent of 
the world’s population are anemic, mainly due to iron deficiency (1).  A large 
contributing factor to this widespread iron deficiency is that an estimated four billion 
people live on a primarily plant based diet (2).  Although iron is abundant in plants, 
plants also contain organic compounds, such as phytic acid, that reduce the 
bioavailability of iron.  Consequently, between only one to fifteen percent of iron 
consumed from a plant diet can be absorbed by the body (3).  This is in contrast to a diet 
containing sufficient amounts of animal protein, particularly red meat, which is rich in 
heme-iron.  Fifteen to forty percent of heme-iron that is ingested is absorbed through the 
intestine (4). 
In humans, sixty-five to seventy-five percent of iron in the body is incorporated 
into heme (5).  Heme is a tetrapyrrole that serves as a cofactor for numerous proteins, 
including the globins and cytochromes.  Heme-containing proteins exhibit a wide array of 
functions including oxidative metabolism, gene regulation, cell differentiation, and gas 
sensing (6-9). Within the cell, heme functions as both a catalyst for reduction-oxidation 
reactions and an electron carrier (10).   
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The heme synthesis pathway has been studied in detail.  There are eight genes in 
the synthesis pathway, all of which have been cloned, and the enzymes they encode for 
have been crystallized (10).  Several diseases, such as X-linked sideroblastic anemia and 
the porphyrias, are associated with mutations in the heme synthesis pathway (11,12). 
Despite the progress made in deciphering the synthesis pathway, the intercellular and 
intracellular transport of heme remains poorly understood.  The transport of heme is 
likely to be highly regulated due to the hydrophobic and cytotoxic nature of heme.  As a 
hydrophobic molecule, heme cannot simply diffuse throughout the aqueous environment 
of the cytoplasm.  Additionally, each heme ring contains an iron molecule that can 
generate free radicals within the cell via peroxidase reactions.  Therefore, it is likely that, 
as with iron, heme is sequestered and protected for safe and efficient delivery to different 
cellular compartments for incorporation into hemoproteins. 
Studying cellular heme transport and homeostasis has been difficult due to the 
challenges in uncoupling heme synthesis from trafficking.  The difficulty occurs because 
heme synthesis is highly regulated, and several mechanisms exist to ensure that cells 
maintain proper physiological heme levels.  Therefore, depleting cells of endogenous 
heme causes many pleiotropic effects, which prevents the identification of specific 
trafficking molecules.  However, we have previously shown that C. elegans is a heme 
auxotroph, making it an excellent genetic model for studying heme trafficking (13).  As 
heme trafficking molecules are identified, the genomic sequences that code for these 
proteins can be analyzed to determine how they are regulated.  One mode of regulation 
would be at the transcriptional level.  Thus, uncovering functional, non-coding DNA 
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sequences, such as enhancer and repressor elements, of heme transport genes will give a 
better understanding of how organisms maintain heme homeostasis. 
Studies that identify molecules involved in heme trafficking and homeostasis have 
important nutritional and biomedical ramifications.  Discovering human orthologs 
involved in heme homeostasis could facilitate the creation of iron sources that are more 
bioavailable to humans.  Additionally, nematode specific-genes may be potential drug 
targets for helminthic infections.  It is not only soil-dwelling nematodes that require 
expgenous heme, but several species of parasitic nematodes require heme from the diet 
(13).  Parasitic nematodes have become increasingly resistant to drugs, yet development 
of new anthelminthic drugs has remained slow for the past 25 years (14).  Targeting 




In most eukaryotes and prokaryotes, heme is synthesized via a conserved eight-
step pathway.  The pathway is outlined in Figure 1.  In eukaryotes, the first reaction and 
the last three reactions take place in the mitochondria, while the remainder of the 
reactions occurs in the cytosol.  All eight genes in the heme synthesis pathway have been 
cloned, and the associated enzymes have been crystallized (10).  The first step in heme 
biosynthesis is the reaction between glycine and succinyl-coenzyme A (succinyl-CoA), 
which results in the formation of 5-aminolevulinic acid (ALA).  This reaction is catalyzed 
by aminolevulinic acid synthase (ALAS).  ALAS utilizes the active form of vitamin B6, 
pyridoxal 5-phosphate (PLP), as a cofactor.  PLP binds to a lysine of ALAS, leading to  
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Figure 1: Eukaryotic heme biosynthesis pathway.  
The heme biosynthetic pathway occurs in eight conserved steps.  The first and last three 
steps take place in the mitochondria.  The middle four steps take place in the cytosol. 
Mitochondrial enzymes are depicted in green and cytosolic enzymes in red.  




the formation of a PLP-glycine Schiff base complex.  The complex then interacts with 
succinyl-CoA, catalyzing the formation of ALA.  Following synthesis, ALA is exported 
from the mitochondria by an unknown mechanism. 
Once in the cytosol, aminolevulinic acid dehydatase (ALAD) catalyzes the 
condensation of two ALA molecules to form the pyrrole porphobilinogen (PBG).  Zinc is 
required for ALAD function, consequently heme production is dependent on the 
availability of zinc (15).  ALAD is composed of four homodimers, with one active site 
per dimer (16).  Each active site binds two ALA molecules.  One ALA molecule will 
contribute the acetate and amino-methyl group of PBG, while the other molecule will be 
responsible for the propionate side chain and the pyrrole nitrogen (10).  This reaction 
completes the formation of a pyrrole. 
The next two steps in the synthesis pathway are responsible for combining four 
porphobilinogen molecules to form a tetrapyrrole.  The first of the two reactions is 
catalyzed by porphobilinogen deaminase (PBGD), which catalyzes the formation of a 
polymer of four molecules of PBG.  The product of this reaction is hydroxymethylbilane 
(HMB).  PBGD utilizes a dipyrrole cofactor derived from PBG molecules.  The enzyme 
binds an HMB molecule, then subsequently adds two additional pyrroles to form a 
hexapyrrole.  The four pyrroles distal from the active site of PBGD are cleaved, forming 
HMB.  The two proximal pyrroles are retained for the active site (17).   HMB released 
from PBGD is unstable and must be quickly converted to uroporphyrinogen III 
(UROgenIII) by the enzyme uroporphyrinogen III synthase (UROS).  UROS flips the 
“D” ring of HMB and catalyzes ring closure to form a tetrapyrrole macrocycle. 
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UROgenIII can enter different synthesis pathways.  In mammals, UROgenIII can 
enter the heme biosynthetic pathway or the corrin synthesis pathway.  In photosynthetic 
organisms UROgenIII can also enter the chlorophyll synthesis pathway (10) 
The next two reactions in the heme synthesis pathway modify the side chains of 
the tetrapyrrole.  In the first reaction, UROgenIII is converted to coproporphyrinogen III 
(CPgenIII) by the enzyme uroporphyrinogen decarboxylase (UROD), which removes the 
carboxylic acid groups of the tetrapyrrole’s four acetic acid side chains.  The next side 
chain modification is catalyzed by coproporphyrinogen oxidase (CPOX), which is 
located on the intramembrane space side of the outer mitochondrial membrane.  In order 
for CPOX to have access to CPgenIII, the substrate must be imported into the 
mitochondria.  It has been reported that the ATP-binding cassette transporter ABCB6 is 
the CPgenIII mitochondrial transporter (18).  However, this finding has been 
controversial due to the substrate used for binding and uptake assays  The study used 
planar, oxidized coproporphyrin III instead of the physiological CPgenIII, which is 
reduced and non-planar (19).  CPOX catalyzes the oxidative decarboxylation of the 
propionate groups of pyrroles A and B, which results in the formation of 
protoporphyrinogen IX (PPgenIX).  CPOX has been reported as the rate limiting enzyme 
in heme synthesis during erythroid differentiation (20).  The second to last step of the 
pathway is the oxidation of PPgenIX by protoporphyrinogen oxidase (PPOX) to form 
protoporphyrin IX (PPIX).  PPOX is located on the outer surface of the inner 
mitochondrial membrane and functions as a homodimer (21). 
The final step of heme biosynthesis is the addition of iron into PPIX to form 
heme.  The reaction is catalyzed by ferrochelatase (FECH).  Ferrochelatase is located on 
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matrix side of the mitochondrial inner membrane.  Due to the spatial arrangement of the 
final three enzymes and the chemical reactivity of intermediates, it has been suggested 
that CPOX, PPOX and FECH may form a complex to facilitate the terminal steps of 
heme synthesis (21,22)    
 
Differential regulation of the heme synthetic pathway in erythroid and non-
erythroid cells 
By necessity, the heme synthesis pathway is a highly regulated process.  Heme 
production must be coordinated with different environmental conditions, especially iron 
availability.  Accumulation of porphyrins, iron, or heme itself is toxic to the cell.  As a 
result, synthesis must be tightly controlled.  Additionally, cells of different tissues have 
different heme requirements, and the pathway must be regulated accordingly. 
Non-erythroid cells, especially hepatic cells, need to adapt to the changing 
metabolic state of the organism and, therefore, need to adjust the amount of heme that is 
synthesized.  Heme produced in non-erythroid tissue is primarily for use within each cell 
for incorporation into proteins such as the cytochromes. 
Erythroid precursors need to produce a greater amount of heme than other tissues 
for insertion into hemoglobin.  In contrast to other cell types, heme produced in erythroid 
tissue will be used to deliver oxygen to all tissues of the body.  Therefore, erythroid 
precursors produce heme as long as iron is available.  Upregulation of heme synthesis in 
erythrocytes at the transcriptional level is mainly achieved via erythroid-specific 
transcription factors. 
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Differential transcriptional regulation is found in the first enzyme of the heme 
synthesis pathway, ALAS.  As shown in Figure 2, mammals have two forms of ALAS 
which are differentially expressed depending on cell type.  ALAS1 is expressed 
ubiquitously, and is the rate-limiting enzyme of heme biosynthesis in non-erythroid tissue 
(10).  ALAS1 has been shown to be downregulated by heme at the transcriptional and 
post transcriptional levels (23,24).  The mechanism that governs downregulation has not 
been determined.  Heme also post-translationally regulates ALAS1 by binding to a heme-
regulatory motif (HRM) (25).  Heme binding to the HRM blocks mitochondrial import, 
resulting in post-translational feedback inhibition. 
In addition to heme, ALAS1 is responsive to glucose (26).  The transcription factor 
PGC-1α is upregulated when glucose levels are low, which in turn upregulates ALAS1.  
Interestingly, ALAS1 is also upregulated by the NPAS-2/BMAL1 complex, which is part 
of the core clock mechanism that controls circadian rhythm (27).  Rev-erbα is a nuclear 
hormone receptor that negatively regulates the NPAS-2/BMAL1 complex in the presence 
of high heme, ultimately leading to a repression of gluconeogenic genes (28).  This may 
be the system that coordinates glucose and heme homeostasis with the core clock 
mechanism, as both processes are at least partly under circadian control. 
 ALAS2 is an erythroid-specific gene and, therefore, has a different regulation 
pattern than ALAS1.  At the transcriptional level, upregulation is achieved during 
erythropoiesis through the binding of erythroid-specific factors to their target sequences 
(23).  Erythroid-specific transcription factors, such as GATA-1 and NF-E1, are 
synthesized specifically in erythroid tissue during erythropoiesis.  Genes such as ALAS2  
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Figure 2: Mammals have two ALAS synthases. 
ALAS1 is a ubiquitous ALAS synthase, the gene of which is located on chromosome 3.  
ALAS2 is an erythroid-specific ALAS synthase whose gene is located on the X 
chromosome.  Chr. = chromosome location. ATG = translational start site.  IRE = Iron 
response element.  H = Housekeeping transcriptional start site.  E = Erythroid 
transcriptional start site.  Blue background = housekeeping specific exons.  Red 
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that have promoters containing binding sites for these transcription factors will be 
upregulated in differentiating erythroid tissue. 
ALAS2 is regulated at the post-transcriptional level by the IRP/IRE system (29).  
The ALAS2 transcript contains an iron response element (IRE) in the 5’ untranslated 
region (UTR) near the translational start site, which binds an iron response protein (IRP) 
when iron is depleted.  The presence of an IRP near the translational start site of the 
ALAS2 mRNA sterically hinders the initiation complex from forming, thereby resulting in 
ALAS2 downregulation in low iron conditions.  When iron levels are sufficient, IRP can 
no longer bind mRNA, which results in the translation of ALAS2.  Thus, erythroid levels 
of ALAS2 are directly linked to iron availability.  This is important physiologically.  
Post-transcriptional regulation of ALA2 allows cells to quickly adjust the heme synthesis 
pathway according to iron levels. 
ALAD encodes the second enzyme in the heme synthesis pathway, and consists of 
eleven coding exons and two non-coding exons (1A and 1B).  Differential regulation is 
achieved by utilizing two different promoters.  In non-erythroid tissue, the gene is 
regulated by a housekeeping promoter located upstream from exon 1A, the transcript of 
which does not contain exon 1B.  The erythroid-specific promoter is located between 
exon 1 and 2, and contains GATA-1 binding sites.  Although the transcripts differ to 
allow for upregulation specifically in erythropoietic tissue , the resulting proteins are 
identical because the translational start site for both transcripts is in exon 2 (30). 
The third and fourth genes in the pathway, PBGD and UROS, are transcriptionally 
regulated in a manner similar to ALAD by a housekeeping promoter in all cell types and 
an erythroid-specific promoter in erythroid tissue, as shown in Figure 3.  In PBGD, the  
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Figure 3: The splice variants of the second, third, and fourth enzymes in the heme 
biosynthetic pathway. 
ALAD, PBGD, and UROS achieve erythroid-specific expression by utilizing erythroid-
specific promoters that result in splice variants.  Chr. = chromosome location.  ATG-C = 
Common transcriptional start site. ATG-H = Housekeeping transcriptional start site. 
ATG-E = Erythroid transcriptional start site.  Blue background = housekeeping specific 
exons.  Red background = Erythroid-specific exons.  Pink background = common exons 
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housekeeping promoter is located upstream of exon 1, while the erythroid-specific 
promoter is in the intron between exon 1 and exon 2 (31).  There are two cis acting  
sequences in the erythroid-specific promoter that are responsible for upregulating 
transcription in erythroid tissue during erythropoiesis.  The first element is located 70 bp 
upstream of the transcriptional start site and binds the erythroid transcription factor NF-
E1.  The second element is located 170 bp upstream of the transcriptional start site and 
binds the erythroid-specific transcription factors NF-E2 and the ubiquitous transcription 
factor AP1 (31).  Unlike ALAD, alternative splicing leads to proteins that differ in the N-
terminus (32). 
In UROS, the housekeeping promoter is located upstream of exon 1 and has 
binding sites for the ubiquitous transcription factors NF1, SP1, AP1, OCT1, and NFR2.  
The resulting mRNA contains exon 1A or exon 1A fused to exon 2B.  The erythroid-
specific promoter, located in intron 1, contains nine GATA-1 binding sites.  These sites 
are sufficient to drive erythroid-specific expression.  mRNA transcribed from the 
erythroid-specific promoter contains exon 2A.  Both the ubiquitous and erythroid-specific 
transcripts have exon 2B, which contains the translational start site.  Consequently, like 
ALAD, the two transcripts code for identical proteins (33). 
The next gene in the pathway, uroporphyrinogen III synthase (UROS), does not 
have an erythroid-specific promoter.  However, transcription is increased in erythroid 
tissues.  The mechanism of regulation remains unclear (34). 
The sixth gene in the heme synthesis pathway, coproporphyrinogen oxidase 
(CPOX), has only one promoter but achieves differential expression through binding of 
erythroid-specific transcription factors to enhancer elements.  The promoter of CPOX has 
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a SP1-like element, a GATA-1 site, and a novel regulatory element, CPRE, which work 
together to regulate transcription (35).  Differential expression in erythroid MEL cells 
and non-erythroid NIH3T3 cells suggests differential regulation between erythroid tissue 
and other cells types, with the GATA-1 site only important in erythroid cells.  
Interestingly, the CPRE element is also found in the human β-globin promoter, another 
gene that is upregulated in erythroid tissue (35).  The transcription factor that binds the 
CPRE element has been shown to be Klp1, which acts as an activator when bound to the 
CPRE (36). 
The second to last gene in the heme synthesis pathway, protoporphyrinogen 
oxidase (PPOX), has also been shown to be differentially expressed in erythroid and non-
erythroid cells.  PPOX is upregulated in erythroid cells when compared to other tissue 
due to two GATA sites contained within exon 1 of the PPOX (37). 
The final gene in the pathway, ferrochelatase (FECH), achieves differential 
expression in a manner similar to the two previous enzymes in the pathway.  There is a 
single promoter which contains binding sites for SP1, NF-E2, and GATA-1.  These 
elements have shown different results depending upon the system used.  In K562 cells, a 
erythroleukemia cell line, the SP1 binding site was sufficient to drive erythroid 
expression of FECH (38).  It has also been shown that a point mutation in one of the SP1 
binding sites disrupts proper transcription of the FECH mRNA and leads to 
erythropoietic protoporphyria (39).  In mouse embryonic stem cells, it was shown that the 
NF-E2 binding site is necessary for both basal expression in pluripotent cells and 
erythroid-specific upregulation.  The same study also demonstrated that GATA SITE 1 
binding element acts as a repressor in pluripotent cells, but an enhancer during 
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erythropoietic development.(40).  FECH expression is also upregulated by iron 
sufficiency and hypoxia.  The iron dependent regulation of FECH is due to an iron-sulfur 
cluster in its C-terminus (41).  It is induced by hypoxia due to two hypoxia inducible 
factor (HIF) binding sites in its promoter (42).  It is not surprising that the synthesis of 
heme is coordinated with iron and oxygen levels because all three molecules are tightly 
linked during aerobic respiration. 
 
Heme as a transcriptional regulator 
Heme has been shown to be a key regulator of several processes at the 
transcriptional level.  Intracellular heme levels are important for the transcriptional 
control of processes such as oxidative metabolism and circadian rhythm.  Heme may also 
promote erythroid differentiation by promoting the expression of p18 and p21 which are 
negative regulators of the cell cycle .  DNA microarray data from K562 cells has shown 
that the expression of several hundred genes was altered due to heme.  When K562 cells 
were treated with heme, some genes were transcriptionally upregulated, while others 
were downregulated, indicating a dual regulatory role for heme (43).  Additionally, 370 
genes in C. elegans were shown to be transcriptionally regulated by heme.  These heme 
responsive genes (hrgs) could be grouped into eight categories depending on their 
transcriptional profile under varying heme concentrations (44).  These studies suggest 
that heme plays a role in the transcriptional regulation of many genes.  Further research is 
needed to uncover the mechanisms that govern heme-dependent transcription, which 
responses are primary, secondary, and tertiary, and the functions of the genes that are 
regulated by heme. 
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The first evidence that heme regulates transcription came from the iso-1-
cytochrome c gene (CYC1) of the electron transport chain in yeast.  Cyc1p is the heme 
binding protein of the cytochrome b-c1 complex.  It was shown that CYC1 was 
transcriptionally upregulated by heme through the heme activation protein 2 (Hap2p) by 
binding to an upstream activation site.  Transcription of CYC1 was reduced 200-fold in 
cells grown in heme deficient conditions (6).  Although the mechanism of heme-response 
has not been deciphered for Hap2p, the proposed mechanism for the heme regulation by 
the Hap2p homologue, Hap1p, is that heme binding causes a conformational change 
which exposes the DNA binding domain.  This structural alteration allows Hap1p to bind 
DNA and act as an enhancer of its target genes (45). 
Transcriptional control of the electron transport chain in response to intracellular 
heme levels is essential for the cell to maintain proper metabolism.  Heme is required for 
aerobic respiration.  In low heme conditions, it is a poor use of energy to produce proteins 
that cannot be utilized.  Subsequently it was shown that COX4, COX5, COR1, and COX6, 
which like CYC1 encode components of the electron transport chain, are transcriptionally 
regulated by heme (46-48).  COX4, COX5, and COR1 do not encode hemoproteins, 
showing that yeast regulation by heme is a general mechanism for components of the 
electron transport chain, not just hemoproteins.   
 In mammals, respiration is also transcriptionally controlled by the amount of 
available heme through the control of hemoglobin production.  Adult hemoglobin is 
produced in erythroid tissue and consists of a heme molecule bound to a tetramer of two 
α-globin chains and two β-globin chains.  In low heme conditions, it is necessary to 
downregulate globin chain production because the aggregation of globin chains is toxic to 
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the cell (49).  The transcriptional regulation of globin chain production by heme is 
mediated through Bach1, the first mammalian transcription factor shown to bind heme.  
The mechanism by which Bach1 regulates globin chain production has been 
demonstrated (50-52).  The β-globin gene locus consists of five genes: ε-globin, Gγ and 
Aγ-globin, β-globin, and the δ-globin gene which are differentially regulated during 
development.  Transcription of all genes in the locus is controlled by a locus control 
region (LCR), which transcriptionally regulates gene expression from a distance of ~60 
kb (53).  Within the LCR there are MARE sequences (MAf Recognition Element) which 
bind the Maf class proteins.  The Maf class proteins have been shown to be repressors or 
activators depending on which partner they heterodimerize to.  One such partner is p45, 
the large subunit of the erythroid-specific transcription factor NF-E2.  The recognition 
sequence for this heterodimer is TGCTGA(G/C)TCA(T/C), which is found in the β-
globin LCR and the α-globin promoter (51,54).  When the Maf / p45 complex binds to its 
target sequence, it will act as an activator.  Members of the Maf family can also interact 
with Bach1 (50).  The Maf / Bach1 heterodimer will bind to the same recognition 
sequence as Maf / p45, but acts as a repressor.  Bach1 can only bind DNA and repress 
transcription when it is not bound to heme.  Therefore Bach1 mediated repression only 
occurs in low heme conditions.  In addition to dissociating from DNA, Bach1 is exported 
from the nucleus upon heme binding (55).  When heme levels are sufficient, heme will 
bind to Bach1, causing it to dissociate from the MARE elements.  The Maf /p45 
heterodimer can then bind to the MARE elements and activate transcription.  It has been 
shown that Bach1 has four cysteine proline (CP) HRMs which are responsible for heme 
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binding.  Deletion of these motifs inhibited Bach1 dissociation from MAREs upon the 
addition of excess heme. 
 Heme Oxygenase 1 (HO-1), which degrades heme into iron, CO, and biliverdin, is 
another gene repressed by Bach1 (56).  Accumulation of heme in the cell is toxic due to 
free radical production.  When heme levels are high, Bach1 dependent repression of HO 
is relieved by a similar mechanism to that of globin chain regulation by Bach1.           
 Ferritin, the protein which is responsible for sequestering free iron in the cell and 
preventing it from causing oxidative damage, is transcriptionally controlled by heme 
through Bach1.  Because heme contains an iron molecule, cells can only produce heme 
when sufficient iron is available.  Consequently, when cellular heme levels are enough to 
degrade Bach1, there is most likely also excess iron in the cell. Therefore, ferritin is 
upregulated under high heme conditions to sequester excess iron (57). 
 Recently work has been done to demonstrate that heme affects the transcriptional 
regulation of circadian clock-controlled genes through the nuclear hormone receptor 
REV-ERBα.  In these studies gluconeogenic genes were downregulated when heme is 
bound to REV-ERBα, probably through the transcription factor BMAL1 (28).  BMAL1 is 
a key component of the circadian rhythm feedback loop, and has been shown to be a 
target of REV-ERBα.  In mammals, heme binding to REV-ERBα allows it to recruit its 
binding partner, NCoR-HDAC3.  This complex will repress transcription when bound to 
its target sequence. 
Heme production and oxidative metabolism have been previously shown to be 
under circadian control (58-61).  It has also been demonstrated that mice deficient in 
Bmal1 have abnormal metabolic patterns (62).  Despite this evidence linking metabolism 
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to circadian rhythm, how these processes are integrated is not understood.  REV-ERBα 
may coordinate the circadian rhythm with heme production and glucose production, 
thereby linking circadian rhythm and oxidative metabolism (28). 
 Heme has also been shown to repress transcription of tartrate-resistant 
phosphatase (TRAP) (63).  TRAP is an iron-containing protein that may function in iron 
homeostasis (64).  Heme has been shown to repress TRAP in peripheral mononuclear 
cells through the heme-responsive element binding proteins (HREBP), which are 
composed of subunits of the Ku antigen (KuAg) and Ref-1 protein.  HREBP interacts 
with a 27 bp heme responsive element (tandem repeats of GAGGC) that represses 
transcription in the presence of heme.  Although the mechanism which governs the heme 
response is unknown, it has been suggested that heme is responsible for bringing all the 
subunits of HREBP together (65). 
Interestingly, TRAP and uteroferrin are transcribed from the same gene but have 
different post-translation modifications.  These modifications lead to the secretion of 
uteroferrin, while TRAP localizes to the lysosomes (66).  If uteroferrin, like TRAP, is 
downregulated by heme, heme concentration may play a role in the regulation of 
maternal iron transfer. 
 
Post -transcriptional regulation 
Iron and heme homeostasis are intricately linked.  In humans, most dietary iron 
comes from heme.  Sixty-five to seventy-five of this iron will be incorporated back into 
heme.  Most of the remaining iron will be stored in the liver as ferritin (5).  Furthermore, 
iron recycling occurs through heme degradation by heme oxygenase 1 (HO-1).  These 
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two molecules are interdependent on each other and need to be co-regulated.  One way of 
achieving reciprocal regulation is through the well characterized-post-transcriptional IRP 
/ IRE system.  Initially characterized as an iron regulatory mechanism, it is now clear that 
heme also plays a crucial role in this system.  Mammals have two iron response proteins, 
IRP1 and IRP2, which are post-translationally regulated by cellular iron levels.  In low 
iron conditions, both IRPs bind to the Iron Response Element (IRE) located in the 
mRNAs of proteins involved in iron metabolism and homeostasis.  When bound to the 
IRE, IRP1 and IRP2 will upregulate or downregulate an mRNA, depending on where in 
the transcript the IRE is located.  If an mRNA has an IRE in its 5’ UTR, binding of an 
IRP prevents the mRNA from being translated.  Consequently, these gene products are 
downregulated in low iron.  If a gene product has an IRE in its 3’ UTR, it prevents the 
mRNA from being degraded.  Gene products with a 3’UTR IRE  are therefore 
upregulated when iron is low (67).   
It has been demonstrated that IRP2 is the stronger regulator of iron homeostasis, 
and its expression is dependent on heme (68,69).  There is no evidence that IRP1 is also 
regulated by heme.  High iron conditions lead to the degradation of IRP2 by the 
proteosome.  Heme binding to an iron dependent domain (IDD) in IRP2 is required for 
this degradation (70).  Interestingly, the IDD shows similar sequence identity to a typical 
HRM.  Heme binding to the IDD causes the oxidation of IRP2, which allows it to be 
recognized by the E3 ligase HOIL-1 and degraded by the proteosome (71).  When iron 
levels are sufficient, heme will be synthesized and consequently bind to IRP2, leading to 
its degradation by the proteosome.  The degradation of IRP2 will cause a shift in iron 
metabolism.  
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This IRP / IRE system is further integrated with heme production through 
ALAS2.  ALAS2 has been shown to have an IRE in its 5’ flanking sequence that is 
sufficient to confer an iron dependent response in erythroid cells (72,73).  Thus, in iron 
deplete conditions heme synthesis is down-regulated at least in part by the inhibited 
translation of ALAS2. 
Heme has also been shown to be involved in microRNA processing.  MicroRNAs 
are short RNAs that play a role in gene regulation at the transcriptional and post-
transcriptional levels.  This process is at least in part regulated by heme.  The RNA 
binding protein DiGeorge critical region-8 (DGCR8) is only active as a dimer.  To 
dimerize, it requires heme.  Once DGCR8 dimerizes, it can bind to primary microRNAs, 
resulting in cleavage by DROSHA to produce mature microRNAs.  These microRNAs 
will then regulate their target genes (74).  Two microRNAs, miR144 and miR451, have 
been shown to be involved in erythropoiesis in zebrafish (75).  An upstream regulatory 
element which binds GATA-1 is required for the upregulation of a single pri-miRNA 
(precursor-RNA) that encodes both miR144 and miR451.  Zebrafish depleted of miR451 
showed impaired maturation of erythroid precursors, indicating that post-transcriptional 
regulation by microRNAs is essential for erythropoiesis.   
 
Heme regulates translation in erythroid cells 
In erythropoiesis, late-stage erythroblasts lose their nuclei to become 
reticulocytes. As they mature into erythrocytes over the next few days, they synthesize 
hemoglobin and other erythroid-specific proteins.  Hemoglobin production must be 
coordinated with heme availability because aggregation of globin chains is toxic to the 
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cell (49). As has been previously discussed, globin chain production is regulated by heme 
at the transcriptional level by Bach1 binding to the promoters of the α-globin and β-
globin genes.  However, mechanisms must exist to regulate globin production after the 
cell has lost its nucleus and transcriptional regulation is no longer possible.  In 
reticulocytes, this regulation is achieved at the translational level by heme regulated eIF-2 
(HRI) kinase (76).  In low heme conditions, when synthesis of globin chains needs to be 
downregulated, HRI is activated.  This allows it to phosphorylate serine 51 of the α-
subunit of the initiation factor (eIF-2).  eIF-2 is normally responsible for recruiting the 
initiator tRNA to the pre-initiation complex, but phosphorylation prevents eIF-2 from 
being utilized for translation, resulting in global reduction in mRNA translation.   
Although the mechanism HRI uses for heme sensing remains to be elucidated, it 
has recently been demonstrated that His 119, His 120, and Cys 409 are the ligands for 
heme binding.  The proline residue adjacent to the Cys 409 is also important for heme 
Fe3+ complex binding (77). 
 
Post-translational regulation by heme 
In order for proper heme homeostasis to occur, the cell must have a way of 
sensing intracellular heme concentration.  This is accomplished by a group of proteins 
that have HRMs.  Not surprisingly, since many cellular processes are regulated by heme, 
proteins with HRMs serve a wide a variety of functions.  The HRM is a short stretch of 
amino acids that is degenerate in most positions, but has an absolutely conserved Cys-Pro 
core and usually a hydrophobic amino acid at the fourth position (78).  The first HRM to 
be discovered was in the yeast transcription factor Hap1p and contains the sequence 
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Lys/Arg-Cys-Pro-Val/Ile-Asp-His (79,80).  This motif is repeated six times in the N-
terminus of Hap1p.  Importantly, HRMs do not bind heme as tightly as the histidine 
coordination ligands of the cytochromes and globins.  In order to act as sensors, sensor 
proteins need to be able to release heme, and, consequently, not bind heme as tightly as 
hemoproteins which utilize heme as a cofactor. 
Several proteins that have been discussed in previous sections utilize the HRM to 
sense heme.  The transcriptional repressor Bach1 is exported from the nucleus when 
heme is bound to the six HRMs present in Bach1 (55,81).  IRP2, which regulates iron-
homeostatic genes post-transcriptionally, is degraded upon heme binding to its HRM 
(68).  Heme binding to the HRM of HRI kinase, the protein that coordinates hemoglobin 
production to heme availability in reticulocytes, causes inactivation of the kinase (76).  
ALAS1, the first enzyme in the heme biosynthetic pathway, is no longer targeted to the 
mitochondria when heme is bound to its HRM (25). 
 
Heme Transport 
Despite attempts to study heme transport in a wide variety of organisms, success 
has been limited to prokaryotes.  Most organisms are heme prototrophs and can 
synthesize heme endogenously.  Heme synthesis and degradation are highly regulated, 
which makes it difficult to distinguish these intracellular processes from heme transport 
(19).  Although a limited number of proteins have been shown to be important for heme 
transport in eukaryotes, there has been greater success in identifying and characterizing 
heme transport in bacteria. 
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Several bacteria species have developed heme transport systems as a way of 
acquiring iron from their surroundings.  Most of the heme transport systems have been 
characterized in pathogenic species because most of the bioavailable iron these species 
encounter within the host organism is in the form of heme.  Since heme is toxic and 
consequently unlikely to be found free within the host environment, pathogenic bacteria 
must be able to acquire it from hemoproteins such as hemoglobin, hemopexin, 
haptoglobin, and albumin.  Gram positive bacteria which lack an outer membrane have 
receptors anchored on the inner membrane that recognize heme.  The heme is transported 
across the membrane by ABC permeases (82).  Heme transport has been more 
extensively studied in gram negative bacteria, which utilize specific outer membrane 
receptors to acquire heme (83).  These receptors can acquire heme directly from 
hemoproteins or from hemophores.  Hemophores are extracellular heme-binding proteins 
produced by the bacteria.  Once bound to its receptor, the energized conformation of 
TonB in the TonB-ExbB-ExbD provides the energy necessary to move the heme or the 
hemophore into the cell (84).  The outer membrane receptors have a TonB box, which is 
the domain of the receptor that interacts directly with TonB.  Once heme has been 
transported across the inner membrane, it is most likely degraded by a bacterial heme-
oxygenase, which releases iron and protoporphyrin IX (85). 
One hemophore system that has been characterized is the heme acquisition system 
(HAS).  The HAS pathway is utilized by several bacteria species, including the pathogens 
Serratia marcescens and Pseudomonas aeruginosa (86,87).  Several of the genes in this 
system are encoded by the has operon.  The operon is under transcriptional control of the 
Fur repressor protein in conjunction with the ECF sigma and anti-sigma factors (88,89).  
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The Has system has several components that are utilized for heme uptake.  HasA is a 
secreted hemophore that binds to heme outside the cell.  HasA is proposed to remove the 
heme from its carrier, as opposed to forming a stable complex with hemoproteins (90).  
HasA is secreted from the cell by an ABC transporter complex.  The complex consists of 
three proteins, HasD, HasE, and HasF (87).  HasD and HasE comprise the inner 
membrane portion of the secretory apparatus.  HasF, which is not part of the has operon, 
codes for the outer membrane portion of secretory complex (91).  HasR is the specific 
receptor for the HasA/heme complex.  HasB, a TonB homolog, provides the energy for 
movement of heme into the cell (92).  The process by which heme is transported from the 
periplasmic space across the inner membrane has not been well described.  
A heme uptake system has also been described in the gram negative pathogen 
Shigella dysenteriae.  It was demonstrated that ShuA, an outer membrane receptor, 
utilizes hemoglobin as a substrate.  Once hemoglobin is bound, ShuA utilizes His86 and 
His420 for heme extraction from hemoglobin and subsequent transport across the outer 
membrane and into the periplasm (93).  Once in the periplasm, heme is sequestered by 
the periplasmic binding protein ShuT.  Heme is then transferred from ShuT to ShuUV, a 
heme-specific ABC transporter.  ShuUV utilizes His252 and His262 to transport heme 
across the inner membrane to ShuS, the cytoplasmic heme binding protein (94).  To 
release iron from the heme molecule, the bacteria most likely employs a heme oxygenase.  
Not all bacteria that require heme utilize it solely as an iron source.  Heme can 
also serve as a protoporphyrin source for several species of bacteria that are lacking 
enzymes needed for tetrapyrrole synthesis (95).  The opportunistic pathogen 
Haemophilus influenzae is a heme auxotroph and, therefore, requires exogenous heme for 
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aerobic metabolism (95).  A hemophore system has been described in H. Influenzae that 
binds hemopexin.  To obtain heme from host hemopexin, it utilizes a gene cluster called 
HxuABC.  The HxuA gene codes for a 100 kDa secreted hemophore that binds 
hemopexin.  HxuB is a membrane protein that forms a pore and allows HxuA to be 
secreted from the cell.  HxuC is the receptor for the HxuA:hemopexin complex (96-98).  
Further research is needed to determine the mechanisms responsible for heme transport 
across the inner membrane and incorporated into hemoproteins 
Despite these extensive studies of heme uptake and transport in bacteria, proteins 
with similar functions in eukaryotes have only recently been identified.  A heme uptake 
system has been described in the opportunistic pathogenic fungus, Candida albicans.  
Like its bacterial counterparts, C. albicans utilizes heme as an iron source because this is 
the most abundant form of bioavailable iron within its human host.  The two proteins 
involved, Rtb5p and Rbt51p, are glycoproteins attached to the plasma membrane by a 
glycophosphatidylinositol (GPI) anchor.  Rbt5p, which appears to be the dominant 
protein in heme utilization, is induced when iron is limiting (99).  Although the 
mechanism of heme uptake by these proteins is not characterized, several mechanisms 
have been proposed.  Rtb5p/Rbt51p could tether heme to the cell surface, facilitating the 
diffusion of heme across the plasma membrane or allowing uptake by an unidentified 
receptor.  The Rtb5p/Rbt51p/heme complex could also be internalized and heme released 
into the cytoplasm (99,100).  More studies are needed to determine the mechanism of 
heme uptake in C. albicans after heme is bound to Rtb5p/Rbt51p. 
In addition to pathogenic bacteria and fungi, metazoans may also utilize heme as 
an iron source.  Studies have indicated the existence of an intestinal heme receptor in the 
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duodenum of pigs and humans, although the molecule has remained elusive (101,102).  
Recently, it was reported that solute carrier 46A1 (SLC46A1) is the mammalian intestinal 
heme transporter, which the authors named heme carrier protein 1 (HCP1) (103).  
However, SLC46A1 was actually found to transport folic acid with high affinity (104).  
SLC46A1 has a much greater affinity for folate than heme, and children with a hereditary 
loss of function in SLC46A1 needed supplemental folate but did not have any defects in 
iron metabolism.  Therefore, the intestinal heme transporter still remains to be identified. 
 In eukaryotes, how heme, synthesized in the mitochondria, is exported and 
subsequently trafficked to other intracellular organelles and possibly to other cells is 
poorly understood. 
Recently, two molecules have been implicated in exporting heme from the cell.  
The feline leukemia virus receptor subgroup C (FLVCR) was shown to mediate the 
efflux of the fluorescent heme analog, zinc mesoporphyrin (ZnMP), from K562 cells and 
rat renal epithelial cells (105).  FLVCR null mice have deformities similar to humans 
with Black-Diamond anemia and die in midgestation (106).  Additionally, these mice 
exhibit proerythroblast maturation arrest.  This data suggest that heme efflux is essential 
for erythropoiesis.  ABCG2, which is also called the breast cancer resistance gene 
(bcrp1), is an ABC protein that confers drug resistance to tumor cells.  ABCG2/BCRP1 
can interact with heme and other porphyrins.  Furthermore, Abcg2/Bcrp1 knockout mice 
accumulate porphyrins.  Based on these observations, it has been hypothesized that 
ABCG2/BCRP1, like FLVCR, functions by exporting porphyrins out of the cell (107). 
The conserved transmembrane-protein HRG-1 has recently been shown to be a 
vesicular heme transporter (44).  C. elegans deficient in HRG-1 had increased 
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accumulation of ZnMP in the intestine, indicating an aberration in heme trafficking.  
Strikingly, when HRG-1 is knocked-down in zebrafish they showed defects in yolk tube 
formation, hydrocephalus, and erythropoiesis.  It is hypothesized that HRG-1 mediates 
cellular heme availability by regulating the movement of heme from an uncharacterized 
endosomal compartment. 
In C. elegans, HRG-1 has been shown to be transcriptionally upregulated >50-
fold by heme (44).  Heme concentrations of ≥10 µM results in little or no hrg-1 
expression.  These results are corroborated by expression of hrg-1::gfp transcriptional 
reporter in worms.  These results indicate that hrg-1 is regulated primarily at the 
transcriptional level either by activation under low heme, repression under high heme, or 
a combination of both.  The present study was conducted to identify the molecular 
mechanism of hrg-1 regulation.  Insights gained from these studies could provide a better 
understanding for how organisms sense and respond to changes in cellular heme levels.  
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Chapter 2: Methods 
Nematode growth conditions 
All experiments except for RNA interference assays were performed with Caenorhabditis 
elegans grown axenically in mCeHR-2 liquid medium supplemented with 20 µM heme at 
20°C (108).  
 
Preparation of hemin-chloride solution 
130 mg hemin chloride (Frontier CAS# 16009-13-8) was added to 18 ml of 0.3 M 
NH4OH.  Concentrated HCl was added until the solution had a pH of 7.5 – 8.0.  The 
solution was brought to 20 ml with 0.3M NH4OH, pH 8.0, to give a final concentration of 
10 mM hemin chloride.     
 
Bleaching 
Nematode suspensions were centrifuged at 800 x g for 5 min at 4°C.  After aspiration of 
the supernatant, 10 ml of 0.1 M NaCl was added to the pellet.  The nematodes were 
resuspended and allowed to settle on ice for 5 min.  After incubation, the supernatant was 
aspirated and 6 ml of 0.1 M NaCl was added to the pellet.  In a separate tube, 1 ml of 5 M 
NaOH was mixed with 2 ml 5 % Chlorox bleach solution.  The NaOH / bleach solution 
was mixed with water (3 ml / 6 ml) and added to the nematode population.  The 
suspension was intermittently vortexed for 5 min until the cuticles of gravid worms 
dissolved and the eggs were released, then immediately centrifuged at 800 x g for 45 s at 
4°C.  The supernatant was aspirated, and 10 ml sterile water was added to the egg pellet 
and vortexed for 5 s.  The suspension was centrifuged at 800 x g for 45 s at 4oC.  After 
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aspiration of the supernatant, the egg pellet was washed again with 10 ml sterile water 
and centrifuged at 800 x g for 45 s at 4°C.  The supernatant was aspirated, and the pellet 
was resuspended in 10 ml M9 salt solution (86 mM NaCl, 42 mM Na2HPO4, 22 mM 
KH2PO4, 1 mM MgSO4 7H2O).  The eggs were hatched overnight in the M9 solution at 
20°C on a platform shaker set to 70 rpm. 
 
RNA-mediated interference 
E. coli HT115(DE3) expressing elt-1, elt-2, elt-6 double-stranded RNA from the 
Ahringer library were grown in LB broth supplemented with 4 or 25 µM heme for 5.5 h 
(109).  Two wells per construct of a 12 well nematode growth medium (NGM) agar plate 
were spotted with the bacteria and allowed to induce for 24 h.  Forty L3 larvae expressing 
3 kb of the hrg-1 promoter fused to GFP and the unc-54 UTR (strain IQ6011) grown in 
mCeHR-2 media supplemented with 10 µM heme were placed in each well.  Worms were 
analyzed 48 h after RNAi feeding with a Leica MZ16FA stereo-microscope.  Images 
were acquired by an inverted Leica DMIRE2 fluoresence microscope using a plan 20x 
objective (NA = 0.4). 
 
Bombardment 
Worms with an unc-119 (ed3) mutation, which causes an impaired mobility phenotype, 
were grown in two flasks, each containing 90 ml mCeHR-2 media and 20 µM heme, until 
the population contained ~30,000 gravid worms / ml.  The worms were then transferred 
to 50 ml conical tubes and allowed to settle.  The supernatant was aspirated to remove 
larvae, which take longer to settle than gravid worms.  unc-119 worms were not bleached 
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due to the limited amount of progeny they produce.  About 6,000,000 gravids were 
spread evenly onto a 10 cm2 NGM agar plate and incubated on ice for 30 min.  During 
the incubation, plasmid DNA (prepared from E. coli cultures using Macherey-Nagel 
midi-prep kits) was prepared for bombardment.  Reporter plasmids (10 µg) were mixed 
with 5 µg unc-119 rescue plasmid.  Mutant worms that are successfully transformed with 
the wild-type unc-119 gene show normal movement (110).  The DNA mixture was 
coated onto 2 µm gold beads (Ferro Corporation, Germany).  The DNA coated gold 
beads and unc-119 worms were loaded into the Bio-Rad PDS-1000 particle delivery 
system.  Pressure was built inside the system to 14000 psi, at which point the coated gold 
beads were fired into the worms.  Upon completion of the bombardment, 10 ml of M9 
solution was added to the bombardment plate.  The M9 / worm mixture was spread 
evenly onto 20 NGM agar 10 cm2 plates with a lawn of E. coli strain JM109.  After a 
two-week incubation at 25°C, worms with wild-type movement, which indicated 
successful transformation, were placed onto individual NGM plates.  Only worms 
exhibiting both wild-type movement and GFP expression were propagated for 
experiments.  Each bombardment produced about 5-6 lines carrying extrachromosomal 
arrays.  An integrated line was obtained in ~ 25% of the bombardments.    
 
Injection 
N2 wild-type worms were bleached and incubated at 20°C in M9 buffer overnight to 
synchronize the population.  The following day, ~1000 L1 larvae/ml were placed in 
mCeHR-2 medium supplemented with 20 µM heme for four days, at which time the 
population had developed into young gravid worms.  Roughly 100 worms were aliquoted 
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from the mCeHR-2 media and placed on an NGM plate.  Worms to be injected were 
removed from the NGM plate and placed on a 2 % agarose pad coated with a thin layer of 
immersion oil.  Plasmid DNA for injection was prepared with the Qiagen midi-prep kit.  
The reporter construct was co-injected with a dominant marker, rol-6, into wild-type N2 
worms (111).  Transgenic lines carrying the rol-6 marker can be easily identified by the 
rolling phenotype.  The final concentration of each plasmid was 50 ng / µl.  The DNA 
mixture was loaded into a microinjection needle and manipulated with a Narisihge 
hanging joystick micromanipulator.  The DNA (~10-9 nl was injected into the gonads of 
young gravid worms (P0) with a Femtojet (Eppendorf) set at 20.5 psi.  After injection, 
worms were allowed to recover by placing them on NGM agar plates spotted with E. coli 
strain OP50.  Three days after injection, F1 progeny with the rolling phenotype were 
transferred to individual OP50 plates.  After three days, plates were checked for F2 
progeny with the rolling phenotype.  F2 rollers are an indication that the transgenes were 
segregating.  These worms were maintained as extrachromosomal lines.  Each F2 roller 
was further propagated as a separate transgenic line for experiments. 
 
Cloning 
Constructs hrg-1::gfp, hrg-1∆(-254 – -160)::gfp, hrg-1 ∆(-254 – -99)::gfp, hrg-1∆(-91 – -
16)::gfp, hrg-1∆(-254 – -160, -91 – -16)::gfp, hrg-1m(-159 – -137)::gfp and vha-6:gfp 
were created using the GATEWAY cloning system.  The promoter of interest, GFP, and 
the unc-54  3’ untranslated region (UTR) were cloned by recombination into the entry 
vectors pDONR P4-P1R, pDONR 221, and pDONR P2R-P3, respectively, using the 
GATEWAY BP Clonase kit.  The three entry clones were then recombined into a single 
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destination vector, pDEST R4-R3, using the GATEWAY LR Clonase II plus enzyme kit.  
The mutation of the 23-bp element in construct hrg-1m(-159 – -137)::gfp was generated 
by mutating T G, A C, G G, and C A.  Constructs hrg-1∆(-254 – -160)::vha-
6::gfp , vha-6::hrg-1∆(-254 – -160)::gfp, and hrg-1∆(-254 – -160)::egl-18::gfp were 
created by restriction enzyme cloning.  Fusion PCR was used to create PCR products 
with 159 bp of hrg-1 promoter placed 5’ or 3’ of the vha-6 promoter.  These products 
were cloned into the Fire vector pPD95.67 (purchased from Addgene).  Construct hrg-
1∆(-254 – -160)::egl-18::gfp was created by cloning the 159 bp fragment of the hrg-1 
promoter into the pKKMCS vector (a kind gift from Dr. David Eisenmann).  Constructs 
hrg- m(-159 – -155)::gfp, hrg-1m(-154 – -150)::gfp, hrg-1m(-149 – -145)::gfp, hrg-1m(-
144 – -140)::gfp, and hrg-1m(-141 – -137)::gfp were synthesized by site-directed 
mutagenesis PCR (112,113).  Partially overlapping primers were designed to bind to the 
hrg-1 promoter but included each 5-bp mutation (114).  These primer pairs were used in a 
PCR reaction with hrg-1::gfp as template.  The partially overlapping primers were 
extended in the PCR reaction, creating linear plasmids with the desired mutations. 
 
Heme response 
To assay the heme response of transgenic C. elegans transformed with the reporter 
constructs, worms were bleached to make them axenic and  then placed in M9 buffer 
overnight for synchronization.  The following day, synchronized L1 larvae were placed in 
mCeHR-2 media with either 4 or 100 µM heme.  After 72 hours, worms were removed 
from media and placed on unseeded NGM agar plates.  Worms carrying the transgene of 
interest were separated from non-transgenic worms and analyzed for GFP expression by 
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fluorescence microscopy with a Leica MZ16FA stereo-microscope.  For acquiring 
images of each line, worms were picked from NGM plates onto 2 % agarose pads spotted 
with 10 µl of 10 mM levamisole.  Differential interference contrast (DIC) and 
fluorescence images were acquired with an inverted Leica DMIRE2 fluoresence 
microscope using a plan 20x (NA = 0.4) or plan 40x (NA=0.55) objectives.  
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Chapter 3: Results 
Locating the heme responsive cis element in the hrg-1 promoter 
The conservation of DNA in non-coding regions can indicate regulatory function.  
Such regions can be identified by comparative genomics, a tool that is especially 
powerful in Caenorhabditis because the genomes of several species have been sequenced 
(115).  To determine the potential heme responsive cis elements in the hrg-1 promoter, 
we conducted a DNA sequence alignment using 3 kb of the 5’ upstream sequence from 
the ATG translational start site of C. elegans hrg-1 with its homologs in Caenorhabditis 
briggsae and Caenorhabditis remanei.  The alignment results showed strong 
conservation in the first 200 bp with respect to the ATG start site of the hrg-1 promoter 
(Figure 1).  Within this region were five putative binding cis elements for ELT-2, which 
binds the consensus sequence TGATAA (GATA site).  ELT-2 is a GATA family 
transcription factor that is responsible for the intestinal-specific expression of genes in C. 
elegans (116,117).  We called these GATA sites GATA SITE 1 to GATA SITE 5, with 
GATA SITE 1 being the element closest to the ATG translational start site.  GATA SITE 
3, GATA SITE 4, and GATA 5 were conserved in C. briggsae and remanei and flanked a 
23-bp conserved element.  GATA SITE 1 and GATA SITE 2 were absent in the C. 
briggsae and C. remanei promoters.   
C. elegans has seven GATA family transcription factors which are expressed in 
specific tissues.  To determine if ELT-2, which is intestinal specific, is required for hrg-1 
expression under low heme conditions, a transgenic C. elegans strain (IQ6011), harboring 
an integrated transgene with 3 kb of the hrg-1 promoter fused to gfp and the unc-54  3’ 
UTR, was fed bacteria synthesizing double stranded RNA for elt-1, elt-2, elt-6, or vector 
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only.  ELT-1 and ELT-6 are GATA-family transcription factors which are expressed in 
the hypodermis and seam cells, respectively (118,119).  IQ6011 fed with either vector, 
elt-1, or elt-6 showed strong GFP expression in the intestine at 4 µM heme.  However, 
IQ6011 fed with elt-2 dsRNA showed attenuated expression of GFP at 4 µM heme 
(Figure 2).  These results suggest that ELT-2 is required for hrg-1 expression at low 
heme.  
In addition to the GATA sites, there was a contigious stretch of 23 nucleotides 
that was also conserved in the hrg-1 promoter sequence from C. elegans, C. briggsae, 
and C. remanei.  To investigate whether this conserved region containing the GATA sites 
and the 23-bp element was sufficient for heme responsiveness, the first 254 bp of the hrg-
1 promoter upstream of ATG start site was fused to gfp and the unc-54  3’ UTR.  This 
construct was used to generate transgenic worms by microinjections or microparticle 
bombardment using biolistics.  The transgenic lines generated by both transformation 
methods were placed in either 4 or 100 µM heme for 72 h to evaluate GFP expression.  
Worms were then collected for analysis by fluorescence microscopy.  GFP expression 
was only seen in worms in 4 µM heme.  This result indicates that 254 bp of the hrg-1 
promoter was sufficient for heme responsiveness (Figure 3).  These 254 nucleotides will  
henceforth be referred to as the hrg-1 promoter (hrg-1::gfp).  All the subsequent 
constructs were named according to the regions deleted from hrg-1::gfp (Table 1).  
We next sought to delineate the minimal heme-responsive region within the hrg-1 
promoter.  If the five putative GATA sites were important for intestinal expression but 
not heme-responsiveness, then the hrg-1 promoter should still show a heme response 
even if the two GATA sites upstream of the 23-bp element were removed.  A deletion 
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was made in the hrg-1::gfp construct to remove 95 nucleotides between -254 bp and -160 
bp.  This construct was named hrg-1∆(-254 – -160)::gfp.  This deletion removed GATA 
SITE 4 and GATA SITE 5, which are located directly upstream of the 23-bp element.  
Transgenic worms transformed with hrg-1∆(-254 – -160)::gfp expressed GFP in 4 µM 
heme, but not in 100 µM heme (Figure 4).  This indicated that the 159 bp of the hrg-1 
promoter upstream of the ATG start codon was sufficient to confer heme responsiveness.   
We then sought to determine if the remainder of the conserved region, which 
contained the 23-bp element and GATA SITE 3, was important for heme response.  A 
deletion was made in the hrg-1 promoter which removed the 23-bp conserved sequence 
and GATA SITE 3.  We called this construct hrg-1∆(-254 – -99)::gfp.  Transgenic worms 
expressing hrg-1∆(-254 – -99)::gfp expressed GFP constitutively at low levels in 4 µM 
and 100 µM heme (Figure 5).  The absence of heme responsiveness and low GFP 
expression indicated that the region located between -159 bp and -98 bp of the hrg-1 
promoter may be necessary for both heme regulation and enhanced hrg-1 expression.   
We investigated whether the relative spatial position of the 23-bp element with 
respect to the translational start site was important.  A stretch of non-conserved bases, -
92bp to -16bp, which included GATA SITE 1 and GATA SITE 2, between the 23-bp 
conserved element and the ATG start codon was deleted.  This construct was named hrg-
1∆(-91 – -16)::gfp.  Transgenic worms expressing this GFP construct displayed heme 
responsiveness but it was severely attenuated, suggesting that the 23-bp element may 
have spatial constraints or that GATA SITE 1 and GATA SITE 2 are essential for robust 
expression (Figure 6).  Taken together, these results indicate that the heme-responsive 
element was within a 67 bp region in the hrg-1 promoter (Figure 7).  
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To further confirm our results, deletions from -254 bp to -169 bp and -92 bp to -
15 bp were made in the hrg-1 promoter.  This deletion removed the GATA SITE 1, 
GATA SITE 2, GATA SITE 4, and GATA SITE 5 sites, but retained GATA SITE 3.  
Transgenic worms expressing hrg-1 ∆(-254 – -169, -92 – -15)::gfp had no detectable 
GFP in the presence or absence of heme.  These results suggest that the 23-bp putative 
heme responsive element and GATA SITE 3 are insufficient by themselves for GFP 
expression and that other regions within the deleted portion of the promoter, including the 
GATA elements, are are also required for hrg-1 expression and regulation by heme 
(Figure 8).   
 
The conserved 23-bp element is essential for the expression of hrg-1 
Our deletion analysis suggests that the 23-bp region, between -159 bp and -137 
bp, may be responsible for heme dependent hrg-1 regulation.  This element comprises 
two inverted repeats (Figure 9).  To determine whether the 23-bp element was necessary 
for heme-responsiveness, all 23 nucleotides were changed from a purine to a pyrimidine 
using PCR-based site directed mutagenesis.  This construct was named hrg-1m(-159 – -
137)::gfp.  Stable worm lines, transformed with the mutated element, expressed GFP in 
the anterior and posterior intestine which did not appear to be heme responsive (Figure 
10).  This result indicated that the 23-bp region was necessary for hrg-1 expression.  We 
next wanted to ascertain if a specific portion of the 23-bp conserved region was important 
for heme-responsiveness.  We mutated the 23-bp element five consecutive nucleotides at 
a time.  The only construct that showed a different expression pattern than hrg-1m(-159 – 
-137)::gfp was hrg-1m(-141 – -137)::gfp, in which five nucleotides at the 3’ end of the 
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23-bp element were mutated (Figure 11).  Importantly, GFP expression was repressed in 
the presence of heme in these transgenic worms.  Moreover, these worms expressed GFP 
at a much lower level when exposed to 4 µM heme compared to the hrg-1::gfp construct.  
These results suggest that the five mutated nucleotides at the 3’ end of the 23-bp element 
were important for normal levels of GFP expression, even though heme-mediated 
repression remained intact.   
 
Heme response of the hrg-1 promoter is controlled by enhancers and repressors 
The elt-2 RNAi results suggested that ELT-2, possibly by working through 
GATA sites, is important for hrg-1 expression in the intestine (Figure 2).  The loss of 
GFP expression at 4 µM in worms expressing the mutated 23-bp element indicated that 
this region may contain enhancer elements (Figure 11).  However, mutation of the five 
nucleotides at the 3’ end of the 23- bp element leads to low levels of GFP expression 
suggesting that the 23-bp element may also contain repressor element(s).  To confirm 
these results the hrg-1∆(-254 – -160) deletion construct was fused upstream of the egl-18 
minimal promoter to generate hrg-1∆(-254 – -160)::egl-18::gfp.  The egl-18 minimal 
promoter drives GFP expression in the intestine and several other tissues but is not heme 
responsive (Figure 12) (119).  In 4 µM heme, worms transformed with hrg-1∆(-254 – -
160)::egl-18::gfp showed greater GFP expression than worms transformed with egl-
18::gfp.  Conversely, GFP expression was attenuated at 100 µM heme comared to worms 
expressing egl-18;;gfp (Figure 12).  Based on these observations, we conclude that the 
heme-responsiveness of the hrg-1 promoter is mediated by both enhancer and repressor 
elements.  
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The C. elegans gene vha-6 encodes for a subunit of the vacuolar ATPase that is 
expressed specifically in the worm intestine (120).  The vha-6::gfp reporter is strongly 
expressed in worms grown in both low and high heme (Figure 13).  Importantly, even 
though the vha-6 promoter contains multiple GATA sites and is regulated by ELT-2, this 
feature by itself is insufficient to confer heme responsiveness.  To further investigate the 
repressor activity of the hrg-1promoter, hrg-1∆(-254 – -160)::gfp was either placed 
upstream or downstream of the vha-6 promoter to generate constructs vha-6::hrg-1∆(-
254 – -160)::gfp and hrg-1∆(-254 – -160)::vha-6::gfp, respectively.  We found that hrg-
1∆ (-254 – -160) was not heme responsive when it was situated upstream from the vha-6 
promoter.  However, heme-responsiveness was restored when hrg-1∆ (-254 – -160) was 
positioned downstream from the vha-6 promoter (Figure 13).  We infer that the proximity 
of the hrg-1 promoter to the ATG start site may control GFP expression.  Altogether, our 
results indicate that a 23-bp conserved element and the GATA sites work synergistically 
and are essential for the heme-dependent regulation of hrg-1 (Table 2).   
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Figure 1: Alignment of the hrg-1 promoter in three nematode species 
Three kilobases of the 5’ flanking sequence of hrg-1from C. elegans, C. remanei, and C. 
briggsae were aligned using ClustalW and Boxshade 3.2.1.  A region of several 
conserved elements was found in a 200-bp region directly upstream of the translational 
ATG start site.  Conserved bases are indicated by a black box.  A highly conserved 23-bp 
region is boxed.  GATA sites are highlighted with forward or reverse arrows indicating 
top or bottom strand orientation, respectively.  A conserved spliced leader 1 sequence is 
underlined. 
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C. briggsae  -3030 TGACAACTGTTAGAATATTGGTGATAATATGATGAGTAAATTATCAGTTGACATTTTCTT 
C. remanei   -2992 ---------------------TAATAGTTTT-CAATTAGGTCAACGCTGGA--TTTTCTA 
C. elegans   -3077 ----------------------GACGGTTCC-GGATACCTATAACGTAAAAACCTAAAAT 
 
 
C. briggsae  -2970 GCTATTTTTCATAGAAATCAAGATAATTGAGCTC----AGATTTGACGGTGTGGGTGGGC 
C. remanei   -2969 GCTGGAGTT-GTTGAGCGAAAGGCGATAGAGTTTGATGAAATGAGAGATTATGAGAAGAT 
C. elegans   -3004 GGTCGAATTTTGTAATGAAACTTCTATAAAATTTTTTGAAGATTTCTGTGGTCGTTCAAA 
 
 
C. briggsae  -2914 TTATGTCGGAGGGAATACGGTATCAGTGACGTCAAAAACTTAGTCGCAGGTTTTAGTTCT 
C. remanei   -2910 TTAAGAAGAATGCTATTTTTCACGAGCAGGAATTGGAACTACTGCGCGAGATCCCTACTT 
C. elegans   -2944 ATTTCCAAAACTAACTTTTTTACTAACCTT--------TTTTTTCGAATTATCATCCCTT 
 
 
C. briggsae  -2854 TCACGGTCTCTCTTACAGTAGCTCCACGTTTTCATCAAGTACCGCAGGTGCCGTAAAGAC 
C. remanei   -2850 ACTCCACCATCTTTTCAACTTTCGAATTTAAAAACTAACTGTTATA--CTCTGCAAGGGT 
C. elegans   -2862 ATTGAAAACTTTTGTAATTTATCTTACGTTAT-ATCAATAATTA-AGGTACTTTGAAAAC 
 
 
C. briggsae  -2794 TCTGACAG----AACGCCACTTGGACCGTCCACTTTGAGCTTATGAATCTCACTTCTTTT 
C. remanei   -2792 TCCTGCAGTCCCAAGTGTAGCTAGGCGGTCTACCATA--TCTCCGTACTGGGTTCCAGCA 
C. elegans   -2804 AGTTGCCCTTAAAATGCT--TTAAATGAATTACCTTAATCAACTGAAT--AACGTAAGAA 
 
 
C. briggsae  -2738 GAAAGATGTCAAAAAAT--TGTCGATTAAGAAAATGTTTATCATGATATCAGCAAGATTT 
C. remanei   -2734 AAATTATCCGGTGCTGT--TGCTGGTTGATTCTCCGGTCTTAGCACCTTGACTTTGATAC 
C. elegans   -2748 AAACGCCCAAAATATGCAATAAAGAATAAAAAGTAGTTTTCAAAAAAAAAAAGTCAATTT 
 
 
C. briggsae  -2680 T--ATTAGTTAACCTATTTTGATATCTTTCACGGAAAATGGGATACATGGGCTCAGTTTT 
C. remanei   -2676 C--TTTGTTTGATTTCTCTT--TTGCTCCCGTGTGAACTTCTGTAGATTCG-TTATCAGA 
C. elegans   -2688 CCAACCGCTCCGACACAGAAAATTGGTTAAAATTGGAAAAAGGTTTGCTAAAAGTTTTCG 
 
 
C. briggsae  -2622 GACGATTCGGGTAGCGTTCTAG---TAGAGTGTTTACTGT-AGTTGAATTGCTATGTATA 
C. remanei   -2621 AGCAGTGCCGTCAGCATTCTGAACATTGAGTACAACCTTT-TTCACCACAAATCTATTTG 
C. elegans   -2628 AAGATTTATTACAAAGATCGCTTATTTGAGCACATTTTTAGTCCGTTACTTGTCCTTTAA 
 
 
C. briggsae  -2566 CTGTAA-TACCAGCCCAGTACCACATCCTTAG-TCAAAAATGTTTTCTAATCCCTCCCGT 
C. remanei   -2562 GTTTAACTACCTTCTGAACGGCAGGTGTTGAAATCCAAAAGTTTAGCTGACCGTTTTCTG 
C. elegans   -2568 ACTTGA--ACAATTCAAGT--CAATTTTTGGAATCTGCAAG---AGTTAACTAATTCCGA 
 
 
C. briggsae  -2506 TCTACCCTCCCAAAAATCCCTCTGAAACAGAATAAACTAACTTTCGTAAATCATCAAAAG 
C. remanei   -2502 GGAGCGCCTCTTTTGGTTCC----AAATTCTTTGCTTCTATTTTCTTCAGT---TCGATT 
C. elegans   -2513 GTCGAATCGGCATTTATAAAAGAAACGCGGAAATGCAAAACTGTCGAGAAAGGAGGAACA 
 
 
C. briggsae  -2446 TGTCTCGGTTCCACGATTGACCATCTCCGTCAGATAATATCCATATTCCTGTCCTGCG-A 
C. remanei   -2449 TGTTTCGGCTCCT----------TCTC-----GACATTGTTTCTATCTTTCTTCT-CG-G 
C. elegans   -2453 AGCAACGAACTCGAGGT--AGCGGGGGAGGCGAGAGGGGTTCAGATTTTTGATCGTCGTG 
 
 
C. briggsae  -2387 AAAAATTTGGCGCTGTCACTGGCATGTTTTCCGGACGGACCACTTTCACCTTCTTTTGTT 
C. remanei   -2404 TAACTTCCACAGTCG--ACAAACATGGCATTTGAATGAAGAG-----ACCTGGACTTGTT 
C. elegans   -2395 AAAGCTTTACAGTTGG-AAAAAAGGAACTTTTGTTTCTAAGCCA---AGTGGAGAGTACA 
 
 
C. briggsae  -2327 TGGAGTCCTTCTCGGATTTGGTATCTTCTCCTTTTTTCATCGGAATAAGTTTCGCCTCCA 
C. remanei   -2351 ---GATCCATACCCAGTGTCGCATTGACTGCCATATGTGCGGGAAAACAAACTTTCTCTC 
C. elegans   -2339 ---GTACCACCAACAATGTAAAAAGTGTAACTTGTTTTGGTTCAAAACATAA-ACATACA 
 
 
C. briggsae  -2267 TTTTGAACATATCCACCAAAGTTTTCGGAGAACCTTTTTTCTTCAGTTCAGCAATTCGGG 
C. remanei   -2294 TTTTGATAGTCTTTCAGACGAGCTTCAG----CTTGCGCGGAGCTGCATGGTTGATCAG- 




C. briggsae  -2207 CTTCCTCTATTTTCGTTTCTTCTTCACTGTCATTTTGTGCAGTTGCCACTGGTGGAAATT 
C. remanei   -2239 -CTCCCCAAGTTTCAAAATCAGTGAAGATTGAATAATCGCTGGTACGAC--GAACAGCTC 
C. elegans   -2221 -AAACTGTGATGATAAACAAGGCGTATTAAGAAGAACGACATAATCAAC-----CTTGTC 
 
 
C. briggsae  -2147 TCGAAAAAATAGTCGGACGTGGGCTCA--CTGATGAATACCCGGTGTCAGAGTTTTGTCG 
C. remanei   -2182 CAGAACGGTTCGTGCTCAGAGGGATCA--CTGCAGAAGATCTCATATCGACATTTCTCCA 
C. elegans   -2166 CCGACCATCCTCTCTTCTATAACGTTAATTTGTCAAGAAACCTGTCACTCAGTTTTTGCA 
 
 
C. briggsae  -2089 GCAGCGAGCCTCTGCCTGAGCCGAACTGCAAGGTTCGTTG-CTATCATAGCCAAGT-TCC 
C. remanei   -2124 TTCAAACTTTCTTCCAACATACGGAGTGTCCTTTCTTTTAACTGGCATTTGAGATTCTTC 
C. elegans   -2106 ATTCTAAATCC-----AAACAAAAGTTGTTTTTAAAAAAACATAATAACTTCGATTTCTC 
 
 
C. briggsae  -2031 AAT-TGATTCGAAGACGAGTA--AGAACTATTTGTCCGGACATAACTCTCTTTTTTGATC 
C. remanei   -2064 GGC-GCATTTGATGATTGCTCC-ACTGTTATCTTTCAGAATATATGACGACGTAACATCT 
C. elegans   -2051 AGCAGTAACTCTTAACCATAGAAAAAAATTTCAGTAGAAACAAAAATGCCGATAGATTTT 
 
 
C. briggsae -1973 GGTTTTGGAGTAGAAAAAACAACTTTGACGCCGTTTGTGACAGAATTGGCAGATGGTTGA 
C. remanei  -2006 GAGATAGTGTTCGGGTCCACCTTCTTCTTCTCATTTGTTGGATTCTCTGCCAGAAGTAAT 
C. elegans  -1991 GAAACAAAGTACATGAAAAAGAGCGGCCACTCGGTTCCGAAACCATTAGC-GGGGGCGA- 
 
 
C. briggsae -1913 CGATTTCTTTCCGATGGGGCGAAAACTTTCTTAGGAGACATTGTCTTCTCTGGTGGCTCT 
C. remanei  -1946 CCCGACAGATCCATTGTAGTTTACACCTA--TAACACATATTTGGAAACGATAAGATACA 
C. elegans  -1933 --CTGTAAAACAAATGCACTGACAAAAAAGCTGAAAGGCGGATAAATCACGTGAGTTCTA 
 
 
C. briggsae -1853 TCTGGTAACGTTGGCAGTGGTTTCTTATCCATTATGGCTGATACCTGGAAGATGAAGAGT 
C. remanei  -1888 TATGAAGATACTTAAAGGGAAGAATTAAGGAAAAGTACGGA-AGAAAACAGAAGAGAAAA 
C. elegans  -1875 GGCATTCTAGACCATCGCAATGATTTTCAAGGAGCCATGAACATTGATACCAAAGAAAAA 
 
 
C. briggsae -1793 GAGGATAGGCAAAGATTAGAATTGGCGG---CTGTGAAACAGGGAGGCGAGAGGA--GAG 
C. remanei  -1829 GAAGAGAAGAAGAGAGCTCGGCCGGTCGAGTCTATGTCCGAACCGACCGAAAAAACCGAA 
C. elegans  -1815 ACAGAGAGAAAGAAGAATGAAAGGGCA-----TGTGAACGA-CGAGCGGCAAACA--GAA 
 
 
C. briggsae -1738 CCGTTACTATTGGCAAACGGTTATACCAGAAAACTG-ACTGAACGCGCGACCGGCATCGG 
C. remanei  -1769 CGAATGCCAACGGCCAAGGGGCGGGTCATAAAAGCA-AAACAGTGCCAGAAAAGAAGAGG 
C. elegans  -1763 TGGTCCCCGCCG-CCAATCAATGAATTATGAGTGAGTGGACGACATCTGTTGCGCGGCAA 
 
 
C. briggsae -1679 CCTTGGGGGCGGAGCTATAGACA-----GCCGAAC--TAGAGAGTATAGCTTGTGTTAGA 
C. remanei  -1710 GCGCCCACGTGCATAGATTGTCTTTTTCGTCAAGTGTCGAAAAATGAGGTATTGATTTGA 
C. elegans  -1704 AACTGTGCGCGAGATGAGTTACTTTT-CGTCACGT-CTCCTCTTCATAATCTCCCTCTCT 
 
 
C. briggsae -1626 GGGTATGTGTGGATGTTCGTTTCGGTATGGAATAATATCAATTGTGATG----AGTTAGA 
C. remanei  -1650 TGG-ATGCATAGAGGTATGTTTT--TTTGCAAGAATGGCAACAGTGTTGTTTCAATCAAA 
C. elegans  -1646 C----TCTCTCGCGGTGTTCTTCTCTCTCTCTCTATTTCTACAATGTC-------TCCAT 
 
 
C. briggsae -1570 GGCTATTGGAGAGACAACTTAAAAGTAGGAGAAGTACGAAATGTTGCTTTATAAACTTA- 
C. remanei  -1593 AGTGTTTTGCCAAAAACCGTCGAG--AGAGGAAACCGTTTATGGTGCGATAAAAACATCG 
C. elegans  -1598 TATATTACATTAGGTCACTCGTTGTTGCAATTGACCGCTTGTAAATC--TATATTCCTCT 
 
 
C. briggsae -1511 -AAATTTAGTAAGAAAGCAAGCTAAACCAAAAAGCCAAAATGGACGATTTTCATTGGTCA 
C. remanei  -1535 TAAACTCTGCAAATCCAGAACATCCATCGTGAACCGCTAATCATTGAT---AAATGATTA 
C. elegans  -1540 GAATATCGACA------GAAGGTGAGCAATGTTTTTGTGATGTTAGATTCGAATAAGTTG 
 
 
C. briggsae -1452 AATTCAAAATAATAAAACTAGGCGTTGCGTTGGTCATTGCGACTGAGGGACACATCTTAA 
C. remanei  -1478 ATATGAGGCGGAAAGCATCTAAAGAATCAAAAACAATTTGGTTCAAACCAAGGATCCGAA 





C. briggsae -1392 CAATGACAAAGTGTAACAT---TTTTGTGGTCCAACATACACAATGAACA-GTCTAAACG 
C. remanei  -1418 CAATGGAAAAGTGTAATATGTATTTTGTGGGTCAAAACAGCCCACAAATA-GTAATAGAA 
C. elegans  -1429 TAGTTTTCAGTTTTAAA-------TTAAAAATTTACATTTTCGAAGCATATGTGGTCAAA 
 
 
C. briggsae -1336 TCTTAACCAAAAGTTCAACGTTATTGACGACCCGGTTGTTCATCATATTTGTGATAATAA 
C. remanei  -1359 AGTTA-CCAAAAGTTCGA-AATAATAACGACCCGGTTGTTCATTAAAAGTATGATGATAG 
C. elegans  -1376 TGCCG-TAAAAACTGTAAAAAT----GCAACGTGTATTTTTGGTTTTTACAAACTGATTT 
 
 
C. briggsae -1276 AAAAGGAGTAAG---AAAGTGATA--ACTGTTCTGGCCATCAGAATCCTTGGTCAATTGT 
C. remanei  -1301 ACGAGAGATTGGGTGAAAGTGATATAACCGTTCTA-TCTTCATA-----TCGCCAATCCT 
C. elegans  -1321 GAAATAATTGCGTCATGAATCATACACAATTTCTA----TGAAA--TCTTTTCCAAAGTG 
 
 
C. briggsae -1221 ATCTTTCGAGAAATTATTATCGAGATATCAGTCACACCTTTCCTTCCTTTTTTTGT---- 
C. remanei  -1247 TGCCCTCGCCG---TATTGTCGGGAAATCAGTCACACTTTTTTTCCCTTTTTTTTGGCCA 
C. elegans  -1267 AGGCGGAGGCTTGAAACAAGGCAAAAAT--ATCACTGCAATTTTTCCAATTTTTGGTTTA 
 
 
C. briggsae -1167 AAGATAAACAGTTTACTGTCCGAAAAACTGAAGTGTTCACCCCTCGTATTCTGAATCAAA 
C. remanei  -1190 AAAGAAAACAGTTTA-TGTTAAAAGATAT------TTTGTTTCTTAC-TTCTCTATCAAA 
C. elegans  -1207 AATTTTAGTTGCTCAGTACTGTAATTTAT-------GTGTTAACCATGTTGGCATTTA-- 
 
 
C. briggsae -1107 CGATCATAAGAATCGCATGATTTTCTCTTTTCTGTTGGAAGATCCCCAAAAAATGGTTGC 
C. remanei  -1137 CCATCATAACTATCGCATGATCTT-TTTTCTCAACCAGCACATCCCCAAA---------T 
C. elegans  -1156 ---CTAAAAATGTTGAAAGAACAT----ACTGAACCAG-ACGTCTAGGCATGTGGTACAT 
 
 
C. briggsae -1047 TTTCGGCAAAAATACAAAAGCAAAAAGAAATGCACATCCGGTTCCTCGATAATGGGAACA 
C. remanei  -1087 TTTTCACAGAAAAGACAAAGTACATGGCGCATCCGGCTGGCTTCCAAAACGAAAGAGATG 
C. elegans  -1103 AGTTTACAATCATGAGATGG-GTAGCGTAAGCCTGCTAAAATTCAAAAGAGAAGGTGGCA 
 
 
C. briggsae -987  AAGTCAAAAATCGGCAGCAAAAATCATAAACCATCCAAAAAATTGAACTGTTTGGGGAAG 
C. remanei  -1027 CATGGGAACCTGTGCACCGACAAAGAGATTGAAATTTTGGGAGAAATCGTTCACGTGAAT 
C. elegans  -1043 AAC---ACACTTTGAAACAAAGCTGTGAAACACTAACAGAAAGTTCCCAACTATTTTTGT 
 
 
C. briggsae -927 CACGTGGAATACAGGAGGAATATGAAACCACTGTTTTATTGCCTCGGTTTTTTTCTCTTT 
C. remanei  -967 CTTATCCATCACTCGACAATCCGAAAAATAC--CTTTGGTACTGTAGATCTAACATCATG 
C. elegans  -986 AATCATCATTCCTCCGCAAATGTGTGGAAATTTTTCTGCCGGACCAGACGTCTAGACATG 
 
 
C. briggsae -867 TTTCACATGTACCAAAAAAAGCCAGGAGGGGTTTCGATGAAATGAACAGAGATTAATTTG 
C. remanei  -909 TCTCTCCAAATCGAGAAGGAAAAAGGATAGATTTTGGGAAAGTGTAAAGAG-----TGTG 
C. elegans  -926 TAGCATATGGTCTTG---GAACATGGAAAAGGTACAGCCAGCTTCGTGAAG----GTCAA 
 
 
C. briggsae -807 TGCGTCATAAAAATCGTTTTTTTTTCTGGAATGATTACAGTATCTAGATTTCCGAAAAGA 
C. remanei  -854 TACTTCATAGATATGTATGCTCATTTGTAAGTGACAAAAAT-------CTTGCGTGGCGA 
C. elegans  -873 AAGTACAAAGAT-TGGATAAAGTTTTGTTTGTTACCTCAAT-------GTTGGGCCAATG 
 
 
C. briggsae -747 GACAACGGGTAACAGCTATCTTATTCGCAACAGGAGACGTCTTCTCTACCT-TCTTTCTC 
C. remanei  -801 CACCTCTCTTCCCGAACA-CATGAACACATGAACACA-ATACTGTGTGTAT-CGTTTCTC 
C. elegans  -820 TTCGAACCAATCTGAAAAGAATAC-CGGATGACTTCAAATTTTTGAAAAATGTGCCCCAG 
 
 
C. briggsae -688 TAGCACCCTCT---TCGTTTCTA-GCTCTA--TTTTTAGGGATGGA-GGTCAACATCT-G 
C. remanei  -744 TGGCACTCTCCAACTGGTCTCTTTACTCTT--CTGCAAACGATAAAAGGTCACCTGCTAG 
C. elegans  -761 TATCGAAGTATATAAGAATTCTTAACCTTCGGTCACATAAAATAAAAAAATAATTTTTGG 
 
 
C. briggsae -635 CGGACCGTCTTGTGTGTGTTAGTTGATCGTCTTCTGTTCATAGAACGGACCAGT--TTAT 
C. remanei  -686 TGGCCCCTCTCGCATCCATCTGTC--TTTTCCATCATCGGAAAGAGGGAGTACCCCTTAT 





C. briggsae -577 CGATTTTCTGGTATTTTCTGTCGTCTAAAAAACGCGT--TC----TGG---CACTCGCAG 
C. remanei  -628 TGATTTTTTTGACATTTGCAT-ATCCAAGAAAAGCGT--TTGGCGTGC---TGATTGTGA 
C. elegans  -641 GATGTTTTGTGCAATGTCTTATGTCTGACCCCTATATAGTTGGTTTGAGCATGATTGGAA 
 
 
C. briggsae -524 AACAA--TT-TGTAAGCTGGTT-TTCAGGTGAGTCTTCAAGA-TGTATGAGTAGAAAATA 
C. remanei  -574 GGTAAGATT-TGGGATTTTCTCATTTTTATGAGTTTTAAGGAGCTTTTGAGTCCAATTAA 
C. elegans  -581 TGCAAAGTTGTAGAAAAACCAAATTTTGATGAGCTCTCAAAA--TTATGAGTGGCAAAAA 
 
 
C. briggsae -467 TTTTTGAGTGGTTTCCCATGTA-AAACTTATAGTAAAATACAAAACATC----TTATTGG 
C. remanei  -515 ---TTGGGTTTTCTCGGCTCTT-ACGTTTATGATAATTCTATAAACGTTGTTATTTTTTA 
C. elegans  -523 CGAAACAATTTTCCCAATTTTTCAAATTTTTTACTGCGGTATATGATTGCTCAATCATTA 
 
 
C. briggsae -412 AAAA---------TCCCCA--TCGATCGTTTGTCCGAA--GATTATAATAGTCACACCTT 
C. remanei  -458 AAAGCGTTGTTTCTTCCAG--TCGATCGTTCCTTATAAATGTTTATAGTTCCTGGTTTGA 
C. elegans  -463 TATGA------TATTCCAAGTTTTGTTATTCATGTTGCAACTTGAAAATTCTTTTTTGTT 
 
 
C. briggsae -365 CAGCT---------TGAGATCTTTGACATTTTTTTCAAAAATCATTTGTCATTATCATT- 
C. remanei  -400 CAACTATGATAAAATAAACCCCTTGCAATTTTTTTCTAAACCAGTTTACTTCTGTACTTG 
C. elegans  -409 TCACCAT------CTACACTGGTTCACAAATACATACAGTGTACCACCACTCAGTTTTTC 
 
 
C. briggsae -315 ---------------ATTATCGGA----------AAAACTTTC-----TTCTCCACTAGG 
C. remanei  -340 CGCACAAAAAGTTTCATAATTGAACTACAAAAAGAAGACACACATACATTCTTTATCATG 
C. elegans  -355 AAATTCAAAAGTACAGAGATCGGAC---------AAAACTTCTCCACATTTCCTATTAAT 
 
 
C. briggsae -265 CC--AACAC--TTTCCATTTTTCTTGAAATTGACAC------TCCACCGTCGGCCT---- 
C. remanei  -280 TC--ATCGTCATTTCAACTTGTCACGCAGGCAACACAAAATTTCCTGAATCGACATTTAT 
C. elegans  -304 TCCAACAATTGTTTCAACCTTTCTGTCAAAGAGCACAG--TTCTCTGAAACGAAATG-AT 
 
 
C. briggsae -218 -GCCCTTAAAC--------AATG------G-AGAGGAGGGGCGTAAAAACAATAGGGGGA 
C. remanei  -222 GACTCCTCCCC--------TGTGTGCCCTA-AAACAAAGGGGGTGAAAACAAT---GGGA 
C. elegans  -247 GACGCCTCCTCCTGGTATGAGTGTGTGATATGAACAAAGCGCGTGAAAACAATGAGAAAA 
 
 
C. briggsae -174 AGCTGATAAGTTTGATAGTGAGAAG---AGCCATATGGTGCAACAATGATTTTGTGATGA 
C. remanei  -174 AAGTGATAAGTT-GATAGTGGGAAGTGAAGCCATATGGTGCAACAATGATTTTCGAATGA 
G5      G4       G3 
C. elegans  -187 GTGCGATAAGTT-GATAGTGGGAAGTCGAGCCATATGGTGCAACAATGATTGTGCAATGA 
 
 
C. briggsae -117 TAACAACTTGAACGCATATATAAGTGGTCTGAGGAAGCGGGTTCTAGTCACA----TTTC 
C. remanei  -115 TAACAGTCTGAAAACATATAAATATGGGAC-AGAAGTGTAGTTTGGGTCCTA----TCTC 
G3  
C. elegans  -127 TAACAGACCGAAAACATATAAATATGGGGGCAGTAGTGTGGTTTGGGTTCTAAGGTTCTT 
                  
 
C. briggsae -61 G----TACTCT-CTATCCCTCCCTTAACAGACATATTTTTCAAATAT--TCTCATTTTT- 
C. remanei  -59 G----TACCG---CATTCGGTACTTTTTGTGCTTACTTTCTAATTTCA-TGTTATTTTTT 
G2   G1
C. elegans  -67 AATTATATCATATCACAATGCACCTTTTCTGACCGTTTCTTTTTCTAAATTGTTTTTTTT 
 
 
C. briggsae -6 -CAGTGCATG 
C. remanei  -7 CCAGTGCATG 
C. elegans  -7 TCAGTGTATG 
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Figure 2: ELT-2 is required for the upregulation of GFP in low heme. 
Transgenic C. elegans strain IQ6011 was generated using 3 kb of the hrg-1 5’ flanking 
sequence and fused to gfp and the unc-54  3’ UTR.  IQ6011 worms were initially cultured 
axenically in mCeHR-2 liquid medium supplemented with 10 µM heme  Synchronized 
L1 larvae were then exposed to HT115 (DE3) bacteria grown in the presence of 4 µM 
heme and induced to produce double stranded RNA against either elt-1, elt-2, or elt-6.  
DIC (left panel) and GFP (right panel) images are 20x.  For fluorescence, images were 
captured using gain = 18, exposure time =0.03 s.  n = 80 P0 worms per treatment.  These 
results are representative of two separate experiments. 
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Figure 3:  A 254 bp region within the hrg-1 promoter is sufficient to elicit heme-
responsiveness. 
hrg-1 5’ flanking sequence (254 bp) was fused to GFP and the unc-54  3’ UTR.  
Transgenic C. elegans strains carrying this hrg-1::gfp construct were made axenic and 
simultaneously synchronized.  L1 larvae were placed in either 4 µM or 100 µM heme for 
72 h.  GFP expression in the worms was analyzed by microscopy.  DIC (left panel) and 
GFP (right panel) images are 40x.  For fluorescence, images were captured using gain = 
18, exposure time =0.09 s.  n = 20 worms per treatment.  The results are representative of 















Figure 4: 159 bp of the hrg-1 promoter is sufficient for heme-response. 
A deletion was made in hrg-1::gfp from -254 bp to -160 bp, leaving the 159 bp directly 
5’ of the translational ATG.  Transgenic C. elegans strains carrying this hrg-1∆(-254 – -
160)::gfp construct were made axenic and simultaneously synchronized.  L1 larvae were 
placed in either 4 µM or 100 µM heme for 72 h.  GFP expression in the worms was 
analyzed by microscopy.  DIC (left panel) and GFP (right panel) images are 40x.  For 
fluorescence, images were captured using gain = 18, exposure time =0.09 s.  n = 20 
worms per treatment.  The results are representative of two experiments from two 
















Figure 5:  The heme responsive element of the hrg-1 promoter lies upstream of –
98bp. 
A deletion was made in hrg-1::gfp from -254 bp to -99 bp, leaving the 98 bp directly 5’ 
of the translational ATG.  Transgenic C. elegans strains carrying this hrg-1∆(-254 – -
99)::gfp construct were made axenic and simultaneously synchronized.  L1 larvae were 
placed in either 4 µM or 100 µM heme for 72 h.  GFP expression in the worms was 
analyzed by microscopy.  DIC (left panel) and GFP (right panel) images are 40x.  For 
fluorescence, images were captured using gain = 18, exposure time =0.09 s.  n = 20 
worms per treatment.  The results are representative of two seperate experiments from an 
injected line of C. elegans. G = GATA 
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Figure 6:  The position of the heme responsive element is not essential for heme 
responsiveness. 
A deletion was made in hrg-1::gfp from -91 bp to -16 bp.  Transgenic C. elegans strains 
carrying this hrg-1∆(-91 – -16)::gfp construct were made axenic and simultaneously 
synchronized.  L1 larvae were placed in either 4 µM or 100 µM heme for 72 h.  GFP 
expression in the worms was analyzed by microscopy.  DIC (left panel) and GFP (right 
panel) images are 40x.  For fluorescence, images were captured using gain = 18, 
exposure time =0.3 s.  n = 20 worms per treatment.  The results are representative of two 
seperate experiments from an integrated line of C. elegans. G = GATA.  Because GFP 
expression in this transgenic strain was weak, a higher exposure time was used to aquire 
the fluorescence images.  Even though worms at 100 µM heme do not express any 
detectable GFP, the autofluorescence from the intestinal gut granules is visible. 
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Figure 7: Schematic representing the heme responsiveness of various reporters 
From the previous constructs analyzed, we inferred that the HRE lies within a region of 
67 bp.  The blue box represents the inferred region containing the HRE.  The 23-bp 




















Figure 8:  A single GATA site is not sufficient for expression of the hrg-1 promoter. 
A deletion was made in hrg-1::gfp from -254 bp to -160 bp and -92 to -16 bp.  
Transgenic C. elegans strains carrying this hrg-1∆(-254 – -159, -92 – -16)::gfp construct 
were made axenic and simultaneously synchronized.  L1 larvae were placed in either 4 
µM or 100 µM heme for 72 h.  GFP expression in the worms was analyzed by 
microscopy.  DIC (left panel) and GFP (right panel) images are 40x.  For fluorescence, 
images were captured using gain = 18, exposure time =0.3 s.  n = 20 worms per 
treatment.  The results are representative of two seperate experiments from two 
bombarded lines of transgenic C. elegans. G = GATA.  Even though worms at 4 µM and 
100 µM heme do not express any detectable GFP, the autofluorescence from the 
intestinal gut granules is visible. 
 60










Deleted Region 20bp 
 61
Figure 9: The 23-bp element of the hrg-1 promoter has two inverted repeats  
Within the 23-bp element of the hrg-1promoter are two inverted repeats, which can 
function as binding sites for transcription factors.  The inverted repeats are shown by bold 








Figure 10: Mutation of the 23-bp conserved element abolishes expression of hrg-1. 
The 23-bp conserved element was mutated in hrg-1::gfp.  Transgenic C. elegans strains 
carrying this hrg-1m(-159 – -137)::gfp construct were made axenic and simultaneously 
synchronized.  L1 larvae were placed in either 4 µM or 100 µM heme for 72 h.  GFP 
expression in the worms was analyzed by microscopy.  DIC (left panel) and GFP (right 
panel) images are 40x.  For fluorescence, images were captured using gain = 18, 
exposure time =0.09 s.  n = 20 worms per treatment.  The results are representative of 
two seperate experiments from two injected lines and two bombarded lines of transgenic 
C. elegans. G = GATA.   
4 µΜ heme 100 µΜ heme 
DIC 
GFP 










Figure 11: The 5 terminal 3’ bp of the 23-bp conserved element are not required for 
repression 
The 23-bp conserved element was mutated five consecutive nucleotides at a time.  
Transgenic C. elegans strains carrying these constructs were made axenic and 
simultaneously synchronized.  L1 larvae were placed in either 4 µM or 100 µM heme for 
72 h.  GFP expression in the worms was analyzed by microscopy.  Only images for 
mutation of the 3’ terminal nucleotides are (11B) shown because all other constructs 
displayed an identical heme-response as the 23-bp mutation (11A).  DIC (left panel) and 
GFP (right panel) images are 40x.  For fluorescence, images were captured using gain = 
18, exposure time =0.09 s.  n = 20 worms per treatment.  The results are representative of 
two seperate experiments from an injected line of C.elegans.  G = GATA.  mt = 
















































Figure 12: The 159 bp heme-responsive fragment of the hrg-1promoter utilizes both 
enhancement and repression in response to heme. 
159 bp heme-responsive fragment of the hrg-1 promoter was placed upstream of the egl-
18 minimal promoter.  Transgenic C. elegans strains carrying egl-18::gfp (12A) or hrg-
1∆ (-254 – -160)::egl-18::gfp (12B) were made axenic and simultaneously synchronized.  
L1 larvae were placed in either 4 µM or 100 µM heme for 72 h.  GFP expression in the 
worms was analyzed by microscopy.  DIC (left panel) and GFP (right panel) images are 
40x.  For fluorescence, images were captured using gain = 18, exposure time =0.09 s.  n 
= 20 worms per treatment.  The results are representative of two seperate experiments 
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Figure 13: The hrg-1 promoter does not confer a heme response to the vha-6 
promoter when placed upstream. 
The 159 bp heme-responsive fragment of the hrg-1 was placed 5’ (13B) and 3’ (13C) of 
the vha-6 promoter.  Transgenic C. elegans strains carrying either one of these two 
constructs or the vha-6::gfp (13A) were made axenic and simultaneously synchronized.  
L1 larvae were placed in either 4 µM or 100 µM heme for 72 h.  GFP expression in the 
worms was analyzed by microscopy.  vha-6::gfp DIC (left panel) and GFP (right panel) 
images are 20x.  For fluorescence, images were captured using gain = 18, exposure time 
=0.09 s.  n = 20 worms per treatment.  The results are representative of two seperate 
experiments from two bombarded line of transgenic C. elegans. hrg-1 ∆(-254 – -
160)::vha-6::gfp and vha-6::hrg-1∆ (-254 – -160)::gfp DIC (left panel) and GFP (right 
panel) images are 40x.  For fluorescence, images were captured using gain = 18, 
exposure time =0.09 s.  n = 20 worms per treatment.  The results are representative of 
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Table 1: Summary of GFP expression in transgenic worms expressing deletion 
constructs. 
The intensity of heme-depednent-GFP expression was quantified by visual inspection. 
++++ = 100% GFP expression.  +++ = 75% GFP expression.  ++ = 50% GFP expression.  
+ = 25% GFP expression.  +/- = <10% GFP expression.  - = no GFP expression.  White 






































































Chapter 4: Discussion 
Heme is a tetrapyrrole that serves as a co-factor for many proteins.  Although the 
heme synthesis pathway has been studied in detail, little is known about how organisms 
maintain heme homeostasis, partly because only a handful of regulatory molecules have 
been identified in metazoans.  We have established C. elegans as a genetically tractable 
animal model to identify the regulatory molecules and dissect the cellular pathways that 
modulate heme homeostasis.  Using microarrays, we identified ~370 genes that are 
transcriptionally responsive to environmental heme (44).  hrg-1, which encodes for a 
heme transporter, is greater than 40 fold upregulated under heme limited conditions but is 
undetectable when environmental heme is ≥10 µM heme.  These results suggest that hrg-
1 transcription is either enhanced under low heme, repressed under high heme, or a 
combination of both.  In this study, we define the minimal promoter of hrg-1 and identify 
an evolutionarily conserved heme responsive element (HRE) in the hrg-1 promoter.  
The regulatory elements of the hrg-1 promoter are conserved in three 
Caenorhabditis species (Results Figure 1).  These three species reside within the same 
habitat, micro-organism rich soil, and consequently are subject to the limited amounts of 
bioavailable heme.  As heme auxotrophs, the physiological utilization of this heme is 
critical for the worms’ survival.  Therefore, it is not surprising that the regulatory 
pathways for heme utilization are conserved.  Although parasitic nematodes reside in a 
different environment than soil-dwelling species, they are also heme auxotrophs.  Thus, it 
is feasible that these helminths may also share similar heme regulatory mechanisms with 
free-living nematodes.  If hrg homologs in parasitic helminths are regulated in a similar 
manner to hrgs in C. elegans, our studies in C. elegans could be used to establish a 
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paradigm for how other parasitic nematodes forage and ingest dietary heme for growth 
and reproduction, which will eventually aid in the development of anthelminthics to 
combat worm infections. 
We have shown that hrg-1is regulated by ELT-2, the transcription factor proposed 
to control all intestinal specific regulation in C. elegans.  Although there are five putative 
ELT-2 binding elements (GATA sites) in the hrg-1 promoter, they may not all be 
functionally equivalent in hrg-1 regulation.  Other genes, such as pho-1 and ges-1, also 
have multiple GATA sites but it was shown that a specific GATA site is important for the 
regulation of each gene (121).  For both genes, the critical GATA site has the sequence 
ACTGATAA.  In the hrg-1 promoter, the closest sequence to this is GATA SITE 3 
(AATGATAA).  When the region containing GATA SITE 3 is moved from its 
endogenous position, expression in the intestine is significantly reduced.  However, 
whether this is due to the spatial rearrangement of GATA SITE 3 or the deletion of 
GATA SITE 1 and GATA SITE 2 needs to be further examined.  It has been shown that 
the ELT-2 homolog of the parasitic species Haemonchus contortus is functionally similar 
to C. elegans ELT-2, providing evidence of similar regulatory mechanisms utilized by 
both C. elegans and parasitic nematodes (122).      
In addition to GATA sites, a 23-bp conserved element is essential for the 
expression of hrg-1.  Data suggest that the spatial position of the element is not critical 
for heme response, but may be important for the enhanced gene expression.  Using 
BLAST searches we have not been able to find this 23-bp element in other hrgs that share 
a similar heme-dependent regulation as hrg-1.  It seems unlikely that hrg-1 would have a 
unique system of regulation when there are other hrgs are also regulated by heme in a 
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similar manner.  We speculate that the binding-site for the trans-acting factor which 
binds to the 23-bp element may be degenerate.   
Preliminary data has suggested that the 23-bp element cannot function 
independent of GATA sites in larvae and adult worms.  However, hrg-1 is expressed as 
early as the 128 stage embryo in all cell types, possibly due to an embryo specific 
transcript, suggesting that during early development hrg-1 expression is independent of 
ELT-2 (O’Connell, Hamza unpublished data).  This is in contrast to other intestinal genes 
such as pho-1, which is gut specific during late embryogenesis (121).  The difference in 
the spatial regulation of hrg-1 may be based upon the source of heme.  Adult worms 
ingest exogenous heme through the intestine.  Heme must pass through these intestinal 
cells before it can be allocated to other cells, so it is logical that transport molecules 
would be highly regulated in the intestine.  Developing embryos, however, aquire heme 
and other nutrients from their mothers.  All embryonic cells may have direct access to 
exogenous heme.  It is, therefore, advantageous to have transport molecules such as 
HRG-1 expressed in all cells.  Because hrg-1 is expressed initially in all cells during 
embryogenesis, it may be possible to mimic this expression pattern in adult worms.  This 
may facilitate the development of GFP-based heme-sensors in extra-intestinal cells to 
elucidate the intercellular heme transport pathways.  It is also equally likely that the 
putative trans-acting enhancer and repressor are expressed only in the intestine from the 
L1 larvae stage to adult.  In this case, these factors may work synergistically with ELT-2 
to specify intestinal expression of hrg-1.  Identifying these factors will be a future priority 
to aid in generating a whole animal heme sensor.  
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Bases on our results, we propose a model in which the regulation of hrg-1 
regulation may be comparable to genes that are regulated by the heme-sensitive 
repressor, Bach1 (Figure 1).  In the presence of high heme, Bach1 is displaced from 
DNA, which allows the Maf / p45 complex to upregulate its target genes.  We speculate 
that a repressor could occupy the 23-bp element of the hrg-1 promoter in the presence of 
high heme levels.  As heme concentration decreases, the repressor is displaced by an 
enhancer which recruits ELT-2.  When both ELT-2 and the enhancers are bound to their 
respective elements, hrg-1 is transcriptionally upregulated.  Another possibility is that 
ELT-2 is always bound to the GATA sites, but the transcription factor that binds the 23-
bp element controls the rate of transcription under different heme concentrations.  A 
system in which GATA elements work in concert with other factors may be a general 
form of regulation in C. elegans.  ELT-2 controls all intestinal genes.  The specific 
control of these genes under different environmental conditions could be achieved 
through the orchestrated recruitment and interaction with distinct enhancers, repressors, 
or modifiers.  Further studies on hrg-1 and other ELT-2 regulated genes will help 
elucidate the mechanisms of regulation. 
 An RNAi screen is currently ongoing in our group to identify the transcription 
factor(s) that bind to the 23-bp element.  These studies will help us understand how 
animals sense and respond to changes in heme levels by altering the expression of 
transporters and other molecules that work together to regulate heme homeostasis.  An in-
depth knowledge of intestinal heme homeostasis may one day lead to the development of 
bioavailable sources of iron that are more efficiently absorbed by humans.   
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Figure 1: Proposed model of hrg-1 regulation by heme 
A repressor binds the 23-bp element in high heme which out competes the binding of an 
enhancer to this same element.  In low heme, the repressor can no longer bind DNA.  An 
enhancer binds the 23-bp element and subsequently recruits ELT-2 to enhance 
transcription of hrg-1.  Red arrow = enhancement.  Blue arrow = transcription.  Red 
crosses = heme.  TFIID = transcription factor II D.  GTFs = general transcription factors.  
Pol II = RNA polymerase II.  Mediator = a transcriptional coactivator. 
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Appendix A: C. elegans strains. 
unc-119(ed3) III; ihEx61(vha-6::gfp,unc-119+)IQ7061
ihEx62(hrg-1∆(-254 – -160)::vha-6::gfp, rol-6+)IQ7062
unc-119(ed3) III; ihEx84(hrg-1∆ (-254 – -160)::egl-18::gfp,unc-
119+)
IQ7084
ihEx83(hrg-1∆ (-254 – -160)::egl-18::gfp, rol-6+)IQ7083
ihEx13(hrg-1m(-141 – -137)::gfp, rol-6+)IQ6011-13
ihEx63(vha-6::hrg-1∆ (-254 – -160)::gfp, rol-6+)IQ7063
unc-119(ed3) III; ihEx82(egl-18::gfp,unc-119+)IQ7082
ihEx81(egl-18::gfp, rol-6+)IQ7081 
ihEx12(hrg-1m(-144 – -140)::gfp, rol-6+)IQ6011-12
ihEx11(hrg-1m(-149 – -145)::gfp, rol-6+)IQ6011-11
ihEx07(hrg-1m(-159 – -137)::gfp, rol-6+)IQ6011-7
ihEx10(hrg-1m(-154 – -150)::gfp, rol-6+)IQ6011-10
ihEx09(hrg-1m(-159 – -155)::gfp, rol-6+)IQ6011-9
unc-119(ed3) III; ihEx08(hrg-1m(-159 – -137)::gfp,unc-119+)IQ6011-8
unc-119(ed3) III; ihEx06(hrg-1∆(-254 – -160, -92 – -16)::gfp,unc-
119+)
IQ6011-6
unc-119(ed3) III; ihIs05(hrg-1 ∆(-91 – -16)::gfp, unc-119+)IQ6011-5
ihEx04(hrg-1 ∆(-254 – -99 )::gfp, rol-6+)
unc-119(ed3) III; ihEx03(hrg-1∆(-254 – -160)::gfp, unc-119+)









Appendix B: Reporter constructs. 
Bombardment,
Injection
The 159-bp heme responsive fragment 
of the hrg-1 promoter upstream of the 
egl-18 promoter
hrg-1∆(-254 – -160)::egl-18::gfp
InjectionThe 159-bp heme responsive fragment 
of the hrg-1 promoter downstream of 
the vha-6 promoter
vha-6::hrg-1∆ (-254 – -160)::gfp
InjectionThe 159-bp heme responsive fragment 
of the hrg-1 promoter upstream of the 
vha-6 promoter
hrg-1∆(-254 – -160)::vha-6::gfp
bombardmentThe vha-6 promoter fused to gfpvha-6::gfp
Bombardment, 
Injection
The egl-18 minimal promoter fused to 
gfp
egl-18::gfp
Injectionbp 19-23 of the 23-bp element were 
mutated
hrg-1m(-141 – -137)::gfp
Injectionbp 1-5 of the 23-bp element were 
mutated
hrg-1m(-159 – -155)::gfp
Injectionbp 16-20 of the 23-bp element were 
mutated
hrg-1m(-144 – -140)::gfp
Injectionbp 11-15 of the 23-bp element were 
mutated
hrg-1m(-149 – -145)::gfp





The 23-bp element of the hrg-1 
promoter was mutated
hrg-1m(-159 – -137)::gfp
BombardmentContains -159 bp – -92 bp, -15 bp – -0 
bp of the hrg-1 promoter
hrg-1∆(-254 – -160, -91 – -16)::gfp
Contains -254 bp – -92 bp, -15 bp – -0 
bp of the promoter
-98 bp – 0 bp of the hrg-1 5’ promoter
Contains -159 bp – 0 bp of the hrg-1 
promoter
Contains-254 bp – 0 bp of the hrg-1 5’
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